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SUMMARY 
Physical and mental health can each have a huge impact on a child’s daily life, and 
whether or not their medical conditions are properly treated can have a lifelong impact on 
their overall health.  In this thesis, we focus on two chronic pediatric conditions, asthma (a 
physical health condition) and depression (a mental health condition).  We aim to evaluate 
selected aspects of the current state of the health care system with respect to these 
conditions.  
In Chapter 2, we first calculate the census tract level distance to receive asthma 
specialist care for children in fourteen states using a centralized optimization model to 
assign patients to providers.  From these distances, we identify which states have better 
access to specialist care, and identify areas in which there is no access to care.  For two 
states, we use this measure of access to care as a predictor in logistic regression models to 
determine the statistical significance of geographic access to asthma specialist care in 
estimating the rate of severe asthma outcomes (ED visits and hospitalizations).   
In Chapter 3 we extend the optimization model to account for visits for asthma care 
that are met by both primary care and asthma specialist providers and divide the children 
with asthma into the Medicaid and non-Medicaid population.  Using CMS MAX data, we 
determine the capacity for pediatric asthma visits for individual providers as well as for 
each provider type.  We then compute the census tract level distance for Medicaid and non-
Medicaid children to receive primary and specialist care from the optimization model 
output, as well as the percent of the need in each census tract that is unmet.   
 xviii 
In Chapter 4 we establish a depression baseline for the Medicaid population using 
the CMS MAX data.  The baseline includes treated prevalence and utilization for Medicaid 
children age 12-17 in twelve states from 2005 to 2012.  The treated prevalence and 
utilization are presented at the state level and by patient stratifications within each state. 
In Chapter 5 we use a matching procedure to create a data set of Medicaid children 
that simulates paired data.  Each child with depression is matched to a child without 
depression but who otherwise has similar characteristics.  Using these pairs of children, we 
compare the visits, prescription fills, and Medicaid charge amounts for non-depression 
related health care in 2010 and 2011 in order to quantify the differences in health care 
utilization and expenditure between the depression and non-depression populations.   
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CHAPTER 1. INTRODUCTION 
Physical and mental health can each have a huge impact on a person’s life, and this 
is true for children as well as adults.  Children are a particularly vulnerable population, 
however, as they lack the ability and resources to manage their own treatment.  In addition, 
whether or not their medical conditions are properly treated can have a lifelong impact on 
their overall health.   
1.1 The Impact of Geographic Access on Severe Health Outcomes for Pediatric 
Asthma 
Asthma is one of the most common chronic pediatric conditions in the United States, 
and it is an excellent candidate condition to study because many of the severe outcomes 
that it causes are preventable.  In order for a child to have well managed asthma and avoid 
unnecessary health outcomes, he or she must be able to receive the medical care he needs.  
In the second chapter, we compute the estimated geographic access to specialist care for 
children in each census tract in Georgia and North Carolina, and then quantify the impact 
of geographic access to asthma specialist care on the rate of severe pediatric asthma 
outcomes.  This analysis provides quantitative evidence for the importance of having 
asthma specialists that can be reached by people from every census tract.  This may be used 
to inform policy concerning state level standards for spatial access to care or in the selection 
of interventions so that access can be improved in the counties where there is the greatest 
room for improvement.   
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1.2 Spatial and Seasonal Access to Primary and Specialist Pediatric Asthma Care 
Knowing that geographic access to asthma care is a significant factor in estimating 
and predicting severe pediatric outcomes leads to further questions and provides 
justification for continued study of potential geographic access to care.  In chapter 3 we 
extend the model from chapter two in three ways: (1) expanding to include seven 
southeastern states; (2) dividing the patients into the Medicaid and the non-Medicaid 
population; (3) including the estimation of access to asthma care to both primary care 
physicians and asthma specialists, both of which are the appropriate source of treatment 
for children with asthma of varying degrees of severity and control. It is well known that 
asthma is impacted by a wide variety of factors, including the weather and allergies, which 
often depend on the season.  Using Medicaid claims data, we are able to confirm that there 
are seasonal trends in the number of office and emergency room visits that are due to 
asthma. We also compute the available capacity for pediatric asthma visits at primary and 
specialist providers that serve the Medicaid population and apply that provider type 
capacity to all of the primary and asthma specialist providers in each state.  The second 
section addresses the questions of if there are significant differences in access to each type 
of care for Medicaid and non-Medicaid patients, and whether or not the variations in 
demand are large enough to cause a change in access to care across the seasons.   
1.3 Healthcare Utilization Among Medicaid-Enrolled Adolescents Diagnosed with 
Depression 
While depression is not as common in children as asthma is, it can impact not only a 
child’s mental health but also his physical health outcomes (including those for asthma).  
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There is not a complete existing baseline analysis of the prevalence of pediatric depression, 
and so we begin by establishing a depression baseline in the Medicaid population that 
includes a detailed breakdown of the population by demographic factors including age, 
gender, race, overall health (measured with the clinical risk group score) and Medicaid 
eligibility code.  This baseline includes summary information about the population with 
depression in 12 states, as well as the utilization of medical services for depression by state 
over the seven-year period 2005-2012. 
1.4 Healthcare Outcome Measurements for Medicaid-Enrolled Children 
Diagnosed with Depression 
After establishing the baseline, we create a data set of children with and without 
depression from the MAX files using a matching procedure that can be treated as paired 
samples for the remainder of the analysis.  Using the pairs of children in each state, we 
conduct a comparison of the utilization and cost of health care per patient per month 
enrolled.  In the analysis, we focus on the visits and charges for non-depression care so that 
we can quantify the impact of comorbid depression on other health outcomes.  This 
comparison provides insight into the monetary value over time of being able to treat a child 




CHAPTER 2. THE IMPACT OF GEOGRAPHIC ACCESS ON 
SEVERE HEALTH OUTCOMES FOR PEDIATRIC ASTHMA  
2.1  Introduction 
Asthma is a common chronic childhood condition, with over 7.1 million American 
children having a current asthma diagnosis[1]. In addition to impairing quality of life, 
asthma contributes significant costs to the healthcare system, particularly for emergency 
department (ED) visits and hospitalizations, which in many cases could be prevented.  The 
prevalence and cost of pediatric asthma demonstrate great disparities. In general, both 
minority populations and economically disadvantaged areas have lower access to asthma 
related healthcare[2].  In 2006 the asthma hospitalization rate for children living in a zip 
code with a median income below $37,000 was 76% higher than for other children[3].  
African American and Hispanic children are more likely to have asthma and to experience 
a severe asthma outcome than White children[4-8]. 
Both the underlying severity of the disease and how well controlled the patient’s 
asthma is contribute to the likelihood that he will have a severe outcome.   Asthma control 
can be difficult to attain, and the importance of control is highlighted throughout the 
literature[9-11].    Unfortunately, many patients lack a correct understanding of what it 
means for their asthma to be controlled, and both patients and physicians alike often do not 
see control as defined by medical guidelines as attainable. [12].   Bianchi et al conclude 
that control is such an telling factor that hospitalizations are representative of uncontrolled, 
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rather than particularly severe, asthma.[13]  Improved adherence by the patients improves 
both asthma and control, and is the focus of multiple interventions[14-17]. 
Receiving proper medical treatment is critical to an asthmatic child’s health.  It is 
well documented in the literature that asthma control plays as large a role in severe 
outcomes as underlying severity, and that regular medical visits are required for most 
children to maintain control over their asthma.  National guidelines recommend between 
two and twelve visits per year for asthma when a child has well controlled asthma, and 
even more frequent visits for those whose asthma is not well controlled.  On average, 
children on Medicaid in Georgia only have office visits for asthma treatment twice per 
year, which is lower than we would anticipate since we do not expect that all children will 
have well controlled asthma.  Therefore, it is likely that many children are not going to the 
doctor for asthma treatment as frequently as is recommended to maintain good control. 
A key contributor to health and healthcare disparities for chronic conditions, 
particularly pediatric asthma, is the insufficient access to healthcare services. Appropriate 
access is important for managing asthma because regular care visits can reduce severe 
outcomes, controlling asthma is at least as important as its severity, and severity and control 
of the disease are not always correlated[18-22]. In this study, we focus specifically on 
geographic access. While financial access is at the forefront of the current health policy 
agenda, it is only salient if care is made accessible and available. Even though asthma is a 
common disease among children, geographic access to care for asthma is insufficient and 
exhibits great disparities.   
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Although it is well understood that geographic access can impact health care 
utilization and health outcomes[23-25] , there is little research that addresses whether this 
relationship varies across states, whether it behaves uniformly across geography within a 
state, and how it differs across different forms of health outcomes.  This is particularly 
important for pediatric asthma, which is the cause of approximately 170,000 childhood 
hospitalizations each year[26]. Understanding the extent of this relationship will suggest 
interventions targeted to reduce severe outcomes.  
Potential access is commonly used in place of realized access[27-38].  In this chapter, 
we study the link between potential geographic access and severe outcomes for pediatric 
asthma while controlling for other potentially contributing factors in Georgia (GA) and 
North Carolina (NC). Improving asthma outcomes is a priority for the Georgia Department 
of Public Health (DoPH), which leads the Georgia Asthma Control Program.  Data 
availability, geographic proximity to GA, and a different distribution of distance to receive 
asthma specialist care contributed to choosing NC as the second state for analysis. We use 
mathematical modeling to estimate geographic access and apply logistic regression to 
quantify the relationship between access and outcomes.  We also investigate the potential 
reduction in severe outcomes with access improvement. 
2.2 Methods 
2.2.1 Model Data Collection 
The number of children with asthma is computed using the US 2010 Census and 
BRFSS survey prevalence estimates. Figure 1 below shows the number of children with a 
current diagnosis of asthma in each county in GA and NC.  Up to 50% of children with 
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asthma may be referred to a specialist, and a new asthma patient should visit the doctor 
every 2-6 weeks until the asthma is controlled.  On average, each child who is referred to 
a specialist is expected to visit the specialist twice per year.  From this information, we 
compute the number of specialist appointments that are needed for each census tract.  It is 
possible that some patients might choose to visit a primary care physician instead of a 
specialist for some or all of their treatment, or require fewer visits to gain control of their 
asthma.  However, to avoid underestimating demand, we do not reduce the number of 
appointments from the values calculated. 
 
Figure 1. Number of children with a current asthma diagnosis per county in GA and 
NC 
We assume that each specialist sees patients for 49 weeks each year, has 40 hours 
per work-week available to see patients, and can see up to two new asthma patients per half 
day.  Each new patient appointment is expected to take 40 minutes, while each returning 
patient appointment is expected to take only 20 minutes.  In order to determine the 
appointment capacity of the specialist, the specific type (allergist or pulmonologist) and 
whether or not he is classified as a pediatric specialist, must be known.  Table 1 below 
summarizes the annual number of appointments available for each specialist type. 
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Table 1. Annual appointments available to pediatric asthma patients for an 







asthma visits per year 
Adult Allergists 75% 50% 1715 
Pediatric Allergists 75% 100% 3920 
Adult Pulmonologist 25% 50% 490 
Pediatric 
Pulmonologist 
25% 100% 1225 
The number of appointments needed per census tract and the number of available 
appointments per specialist office location are data inputs for the optimization model, as 
described in the next section. 
The final data input to the model is the distance between each census tract centroid 
and specialist office.  ArcMap10 was used to geocode each specialist office location and 
calculate the distance between each census tract centroid and specialist location using the 
US Highway Network.   
2.2.2 Study Population 
The population under consideration consists of children ages 5 to 17 estimated to 
have a current diagnosis of asthma in GA and NC. The age group 0 to 4 is excluded because 
of the difficulty of diagnosing asthma for this age group.   The percent of children who had 
a current diagnosis of asthma is reported by age group in Table C3 of the 2010 BRFSS 
survey for GA[39] and by the 2011 National Survey of Children’s Health (NSCH) for 
NC[40].  The census tract population counts of children for each age group were obtained 
from the 2010 Census data Table B09001[41].   It is assumed that prevalence for each age 
group is uniform across each state. The number of asthmatic children in each census tract 
is estimated by multiplying the population with the percent of children in each age group 
 9 
in each state with an asthma diagnosis.  Census tract estimates are computed for use in the 
assignment model, and the estimates are aggregated at the county level, shown in Figure 1 
above, for the regression analysis. 
2.2.3 Overall Approach for Understanding Severe Outcomes 
To predict severe outcomes, we consider covariates that fall into three categories:  
age indicator, health access (which is of primary interest) and socio-economics, to control 
for other factors over the network.  For consistency, the values for all covariates are 
collected or aggregated at the county level. GA has 159 counties and NC has 100.   
In this study, a severe outcome is defined as an ED visit or hospitalization that was 
caused by the child’s asthma.  The response variable is the outcome rate calculated as the 
ratio of ED visits or hospitalizations to the estimated number of children with asthma at 
the county level for each age group.   
For GA, ED visits and hospitalizations in 2010 were obtained from the online 
OASIS database[42]. For NC, the ED visits and hospitalizations for 2009 were obtained 
from the Healthcare Cost and Utilization Project state databases, which contain de-
identified individual records from community hospitals[43, 44]. IRB approval was 
obtained for this research. Severe outcomes were extracted using the ICD9 codes for 




2.2.4 Covariates of Primary Interest: Travel Distances to Asthma Care Providers 
There are three variables for potential access in the model; the county-average 
distances to primary pediatric care (“PrimaryDistance”), the county-average distances to 
asthma specialist care (“SpecialistDistance”), and the intra-county variance of distance to 
specialist care (“VarSpecialistDistance”). We consider this third access measure because 
there can be a large variation across the census tract distances to specialist care.  To control 
for mobility of the population across county lines for hospital care, the number of hospitals 
in each county is included as a potential predictor (“NumberHospitals”)[45].   
We calculate potential geographic access to primary and asthma specialist care 
using recent methodology to match supply and demand[31]. The approach accounts for 
constraints in the network (e.g., mobility) along with potential barriers to care (e.g., 
provider’s willingness to accept patients with Medicaid). The approach uses an 
optimization model that matches patients to providers, mimicking the process through 
which patients or their parents choose physicians.    Similar to Nobles et al[31], we use 
distance as a primary criteria for choosing one physician over another. Using this patient-
provider matching, we estimate the access measure for each census tract, which we 
aggregate at the county level for the regression.  
For primary care, we consider physicians with an National Provider Identifier (NPI) 
classification of Pediatrics, Nurse Practitioner Pediatrics, Family Medicine, and Internal 
Medicine and obtained travel distances for GA and NC from the recent work of Gentilli et 
al[46].   
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For specialist asthma care, we extracted the locations of asthma specialists from the 
NPI Registry using the National Uniform Claim Committee’s taxonomy codes[47].  
Consistent with the identification of asthma specialists in analyses of the importance of 
specialist care in the literature, we considered allergists and pulmonologists as asthma 
specialists[48, 49].  The maximum caseload of visits for pediatric asthma care was adjusted 
depending on the specialty and whether or not the provider has a pediatric designation, and 
is shown in Table 1 above. We computed the street-network distance between specialist 
offices and centroids of the census tracts, representing the location for the entire population 
of the census tract, with ArcGIS software[50].    
The notation and full optimization model description for matching patients with 
providers are listed here, with the mathematical model shown in Figure 2. 
Decision Variables: 
𝑥𝑖𝑗 : percent of patients in census tract i that are assigned to specialist office j  
Data: 
P : the set of all pediatric asthma patients 
D : the set of all specialist offices 
𝑑𝑖𝑗 : distance in miles from the centroid of census tract i to specialist office j 
𝑢𝑗: maximum number of appointments available at specialist office j 
𝑚𝑖: maximum distance a patient in county i can travel to receive specialist care 
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g : Maximum congestion allowed per county 
Model Description:  
Objective: Minimize total assigned driving distance 
Subject to the following constraints: 
1) Each patient is assigned to at most 1 doctor 
2) No more patients are assigned than are in the system 
3) Each doctor has a maximum number of patients that can be assigned 
4) Each patient has a maximum allowable drive distance 
5) At least 90% of patients must be assigned to a doctor 
6) There is a maximum congestion allowed for doctors in each county 
 
Figure 2. Centralized optimization model to assign patients to specialists 
For both Georgia and North Carolina, there is sufficient specialist capacity to meet 
the full demand for specialist appointments.  In addition, patients in every census tract can 
be assigned to a specialist no more than 50 miles from the tract centroid.  Therefore, we 
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were able to require that 100% of the patients be assigned to a physician instead of only 
90%, and the maximum drive distance did not force any patients to remain unassigned.  
The output of the optimization model above is the percent of asthma patients in 
each county that are assigned to each asthma specialist. From these values, we compute the 
average distance that patients in each census tract will travel to receive specialist care, and 
then we further aggregate to obtain the county level distance so that the distance data can 
be matched with the outcomes data at the county level.  This distance is the predictor 
SpecialistDistance in the regression models.  We also use the census tract and county level 
distances to compute the variance of the distance to specialist care within each county, 
which is the predictor VarSpecialistDistance in the regression models.  
We examine the distribution of distances to care for each state along with the 
Pearson’s correlation of the distances. Similarly to Nobles’ work,[31] we estimate the 
spatial correlation on distance to care using Moran’s I measure, used to evaluated 
systematic disparities in geographic access[51]. 
2.2.5 Other Model Covariates 
All socioeconomic variables extracted from the 2010 Census data are restricted to 
data on households that have at least one child under the age of 18[41].  We include an 
indicator (0 or 1) variable (“AgeX-Y”) for whether the response variable is for children in 
each of three age ranges (X to Y) [39, 40]. For income and education, we select among 
potential variables by investigating the strength of the association of these variables with 
the response variable. The variables selected are the median family income 
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(“MedianIncome”) and the percent of the adults with less than a high school diploma 
(“AdultEducation”). 
2.2.6 Statistical Model 
We quantify the impact of geographic access on severe outcomes using logistic 
regression with replications (equivalent to binomial regression), and we generate separate 
models for hospitalizations and ED visits in each state. All of the numeric variables were 
scaled. To reduce the set of explanatory variables from all combinations of the variables 
shown in Table 2, we performed model selection using forward, backward and forward-
backward stepwise regression.  Of the three resulting models for each state and outcome 
pair (GA ED Visits, GA Hospitalizations, NC ED Visits, NC Hospitalizations), the one 
with the smallest AIC value was selected.  
This process can be explained with the following algorithm: 
Let S be the set of states, Georgia and North Carolina 
S = S = {GA, NC} 
Let Y be the set of severe outcomes, ED Visits (ED) and Hospitalizations (H) 
 Y = {ED, H} 
Let R be the set of selection methods, Forward (F), Backward (B), and Forward-Backward 
(FB) 
 R = R = {F, B, FB} 
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Let 𝑀𝑆,𝑌,𝑅 be the set of regression models for each state, severe outcome, and selection 
method with associated AIC values 𝐴𝐼𝐶𝑆,𝑌,𝑅 and 10-fold cross validation (CV) score 𝐶𝑉𝑆,𝑌,𝑅 
ex: 𝑀𝐺𝐴,𝐸𝐷,𝐹 has value 𝐴𝐼𝐶𝐺𝐴,𝐸𝐷,𝐹,  and 𝑀𝑁𝐶,𝐻,𝐵 has value 𝐴𝐼𝐶𝑁𝐶,𝐻,𝐵  
For each state s in S: 
 For each outcome y in Y:  
  For each selection method r in R: 
Perform model selection using method r and obtain final model  𝑀𝑠,𝑦,𝑟 and corresponding 
AIC value, 𝐴𝐼𝐶𝑠,𝑦,𝑟 
  Select model 𝑀𝑠,𝑦,𝑟 corresponding to min{ 𝐴𝐼𝐶𝑠,𝑦,𝐹 , 𝐴𝐼𝐶𝑠,𝑦,𝐵,and  
𝐴𝐼𝐶𝑠,𝑦,𝐹𝐵}end 
The final set of main effect covariates considered in the model is defined in Table 2 below. 
Table 2.  The final set of main effect covariates included for consideration in the 
regression model. The final model also includes interaction terms between these 
covariates. 
Variable Name Description  
AgeX-Y 
Number of children that are X-Y years old 
For GA: 5-8,9-14,15-17  
For NC: 5-9,10-14,15-17 
SpecialistDistance Within- county average distance to an asthma specialist 
VarSpecialistDistance Within- county variance of distance to an asthma specialist  
PrimaryDistance Within- county average distance to a primary care pediatrician 
MedianIncome Median family income households with children under age 18 
AdultEducation 
Percent of the adult population who have less than a high school 
diploma and live in a household with children under age 18 
NumberHospitals Number of hospitals 
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The regression analysis was implemented using the R statistical software.  For 
model interpretation, we point out that understanding the model coefficients is challenging 
mainly because of the presence of interactions between covariates. Generally, a positive 
sign for an interaction term indicates that two covariates influence the odds ratio jointly, 
and thus, a larger value of one covariate increases the importance of the other. The opposite 
is true when the sign is negative.  In the models, any variable that is used in an interaction 
term is also included alone.  
The selected models with the estimated coefficients and their corresponding 
significance p-values are provided in the Table 4 for Georgia and Table 5 for North 
Carolina. 
Poisson regression is frequently used to fit models for count data and rare events, 
both of which are appropriate descriptors of the pediatric asthma severe outcomes data.   
The input data and setup for poisson regression and logistic regression with replications, 
which is the method used to generate the models that are presented, are very similar, and 
are based on the number of events (severe asthma outcomes) and the size of the population 
(the number of asthmatic children).   We fit and performed model selection using the 
poisson family parameter, which uses the appropriate log link function for Poisson 
regression, and compared the resulting models to the selected logistic regression models.  
The models for both types of regression contain identical sets of significant predictors and 
the coefficients have the same signs and similar magnitudes.  The singular exception is the 
difference of only one significant predictor for North Carolina ED Visits, where the logistic 
regression model contains the interaction term between Age Group 9-14 and the variance 
of distance to specialist care, while the poisson model had the interaction between this same 
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age group and the level of parental education instead.  The consistency of the significant 
predictors and the similarities between the coefficient values confirms that the selected 
models are appropriate and provide a good fit for the data. 
We also use the results of the regression model to predict the reduction of ED visits 
if reductions in distance to access care are made.  Specifically, we allow travel distance to 
decrease to 15 miles for primary care, to 5 or 15 miles for specialist care, or both.  Using 
the regression results, we multiply the model coefficients and the predictors (including new 
distances where applicable) to obtain a predicted response. Using the predicted response, 
we take the inverse of the logit function to get the percent of asthmatic children with a 
severe outcome and then multiply by the number of asthmatic children to get the projected 
number of ED visits per county and age group. 
2.3 Results 
2.3.1 Geographic Access to Primary and Specialist Asthma Care 
Figure 1 shows the number of counties with distances (primary or specialist) within 
specific ranges. The maps of travel distances to specialist and primary care are in Figures 
4 and 5 respectively, with summary statistics in Table 3. Overall, in GA there are more 
counties with longer travel distances to asthma care than in NC. Specifically, in NC, the 
maximum distance to receive asthma specialist care is 30 miles, and only 5 counties have 
an average distance greater than 15 miles.  In contrast, the tract level specialist distances in 
GA are as high as 50 miles, with counties having an average distance greater than 30 miles.  
For primary care in GA, 56 counties travel further than 15 miles, while in NC, 11 counties 
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travel further than 15 miles.  Figure 6 shows the difference in access to primary and 
specialist care in both states. 
 








Figure 5. Maps of the census tract level travel distances to specialist care for GA and 
NC. 
Table 3. Summary statistics for the three access variables at the county level in GA 
and NC. 
















Minimum 2.21 2.33 0.10 3.57 1.19 0.85 
Median 13.16 17.20 25.50 8.98 7.53 33.87 
Mean 13.52 18.47 60.16 9.82 8.33 55.28 
Maximum 25.00 50.00 705.33 25.00 28.75 311.50 
Variance 60.49 134.18   16.47 17.30   
  
Figure 6. The difference in the county level distance to receive specialist and 
primary care in GA and NC. 
The Pearson’s correlation between the travel distances to primary and to specialist 
care in GA is 0.3898, while the correlation in NC is 0.0904, shown in Figure 7. Both GA 
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and NC have significant spatial correlation for primary and specialist care, as indicated by 
significant z-values for the local Moran’s I measure, shown in Figure 8. 
 
Figure 7. The scatter plots of primary vs specialist distance for GA and NC with 
linear trend lines and the Pearson correlation coefficient 
Figure 8. The values and z-values for the local Moran’s I for spatial auto-correlation 
of distances to receive primary and asthma specialist care in Georgia and North 
Carolina. 
2.3.2 Regression Results 
 The detailed results of the logistic regression for ED visit and hospitalization rates 
are shown in Appendix A. The results for Georgia are in Table 33.  The results for North 
Carolina are in Table 34.  In all models, geographic access is statistically significant, 
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although through different access variables and in interaction with different factors.  Model 
R-squared values are provided in Appendix A Table 35. 
2.3.3 ED Visit Model: General Results 
 For explaining ED visits in GA, access to primary care and specialist care are 
statistically significant in their interactions with the socioeconomic variables, and access 
to primary care is also significant in relation to the age of the children. The deviance 
residuals for this model are provided in Figure 9. 
 In NC, all three main effects for access are statistically significant by themselves.  
Each main effect also has significant interactions with other covariates, including median 
income and age group 5-8. 
2.3.4 Hospitalization Model: General Results 
 The final selected model for hospitalizations in GA has fewer significant variables 
than the one for ED visits. For the GA hospitalization model, distance to primary care is 
the access variable with the greatest impact because it is significant by itself and in multiple 
interaction terms, while access to specialist care and the variance of this access are only 
significant in one interaction term each.  The adult education is the only socioeconomic 
variable with a significant interaction with the access variables. 
 In NC, however, all three access variables are statistically significant.   These access 
variables are also significant in more interaction terms than in the models for GA 
hospitalizations. Thus, the NC model is more complex than the GA hospitalization model. 
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Figure 9. Deviance residual analysis for the ED visits model for Georgia. 
2.3.5 Projecting Severe Outcome Reduction with Access Improvement 
 We use the fitted regression model to compute the predicted number of severe 
outcomes for each county and age group when the distance is reduced at the specified levels 
while keeping fixed all other predictors in the model.   
 Figure10 presents the number of county/age pairs in each state with a predicted 
reduction in the number of ED visits for each of the four distance interventions. For only 
improving specialist care to be no more than 15 miles, in NC 131 county-age pairs (out of 
300) have a reduction in ED visits, and in GA 191 county-age pairs (out of 477) have a 
reduction in ED visits.  The total reduction in ED visits is higher in NC, but both states 
have more than 30 county-age pairs where annual ED visits are reduced by more than 15.  
 Figure 11 shows the geographic distribution of locations with a positive 
improvement in outcome. For the intervention of specialist care, no more than 15 miles 
(figure far left), adding a reduction of primary care (third from left) only adds 1 new county 
in GA.  In contrast, further reducing specialist care to no more than 5 miles (second from 
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left) adds 10 additional counties although the additional improvement in ED visits is small 
for the counties that already had improvements from the 15-mile max distance intervention. 
 
Figure 10. The graph shows the number of county-age pairs with an expected 
reduction in ED visits under four types of interventions on access. The interventions 
include reducing distance to specialist care to be no more than 5 or 15 miles, 
possibly in combination with reducing the distance to primary care to no more than 
15 miles.   
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Figure 11. Reduction in ED visits when access to primary and specialist care is 
improved. 
2.4 Discussion 
Our study provides evidence for the association between severe pediatric asthma 
outcomes and estimated geographic access to healthcare while it underlines that this 
association is not uniformly impactful across geography or types of care. Existing literature 
has provided evidence for the association between asthma outcomes and a variety of 
socioeconomic and environmental variables, but not geographic access[3, 6, 24, 33, 52, 
53].   Additionally, there is a relationship between race, lower utilization of asthma 
specialists, and the rate of severe asthma outcomes[54].  Mayer discussed the geographic 
proximity of children to a variety of pediatric specialists, but without any connection to 
health outcomes [55]. Other studies analyze the impact of distance on various health 
outcomes and resource utilization[56, 57], but the connection between geographic access 
to care and severe outcomes for pediatric asthma has not been investigated.    
 25 
Geographic access can be quantified using methods such as distance to nearest 
service site[32], gravity-based model[33], or optimization-based models[31] which we use 
in this study. Although this approach requires more computational effort, it provides more 
accurate estimates than other methods, especially for dense healthcare networks[30].  The 
results showed that access to asthma care for pediatric patients varied widely between and 
within states. Interestingly, the correlation in primary and specialist care distances is 
smaller in NC than in GA.  This indicates that children without good spatial access in 
Georgia are more likely to also have poor access to specialist care than the children with 
the same access in North Carolina. 
Because asthma is a chronic condition, we expected to find the relationship between 
geographic access and severe outcomes to be statistically significant. However, we also 
find that the expression of this relationship depends on the outcome measure, ED visit 
versus hospitalization. For example, in GA none of the access variables are significantly 
associated with the occurrence of ED visits by themselves, but access to primary care is 
significantly associated with the occurrence of hospitalizations.  Therefore, we would 
expect that improving access to primary care would have a greater impact on the 
hospitalization rate than the ED visit rate.   
Moreover, a different set of access variables are associated with severe outcome rates 
when comparing GA to NC. For example, unlike in GA, the main effects of all three access 
variables are significant in the corresponding model for NC. Contrasting the models for 
hospitalizations, there are more significant interaction terms involving the access variables 
in NC than in Georgia.  This is an important finding because it points to a state-by-state 
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analysis. Different states will show significance for different forms of access measures, 
suggesting different interventions in improving access, and ultimately, outcomes.  
There are many factors that could lead to differences in the relationship between 
geographic access and health outcomes for the two states, in addition to those included in 
our model. Generally, NC scores higher in multiple state health rankings, both in general 
and with respect to the state Medicaid programs, where the analysis also covers differences 
related to policies [58, 59].  In addition, the overall population density in NC is higher than 
in GA, and the distribution of the population in the two states is different[60].   
Importantly, we find that the impact of geographic access on severe outcomes for 
pediatric asthma is not uniform across geography because of the statistical significance of 
its interaction with the other predictors in the model.   In order to get the maximum benefit 
from any intervention it should be tailed such that it will target regions that have the 
potential to show the highest impact.  For instance, if the goal were to reduce the number 
of ED visits in GA, we would expect to see the greatest reduction by improving access to 
primary care in areas where the percent of adults with less than a high school diploma is 
higher, and by improving access to primary or specialist care in lower income areas.  
We also project the level of ED visits reduction when improving access (decreasing 
the distance to receive care to certain levels). We compared four interventions for 
improving access to specialist and primary care in GA.  We find that there is a significant 
spatial trend in the ED visits reduction with a more significant reduction in urban areas 
when the distance is reduced to 5 miles. This suggests that if geographic access is improved 
only at the level of 15 miles, primarily rural areas should be targeted for intervention.  
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Moreover, the decrease in distance from 15 to 5 miles generally improves outcomes only 
marginally, while the joint improvement of access to primary and specialist care does not 
lead to a noticeably greater impact on the reduction of ED visits than improving specialist 
distances alone. This suggests that access to specialist care plays an important role in 
reduction of severe outcomes, while a level of access similar to the comparative state of 
NC will suffice. 
There are several limitations of this study.  The first is the unavailability of detailed 
data on severe outcomes and other explanatory variables, especially at the census tract level 
since many data sets only provide state or county level information.  Each county in 
Georgia has between 1 and 204 census tracts, and in larger counties there is high within-
county variation in all of the predictors.  Thus, a county level analysis loses some of the 
descriptive and predictive abilities of the model.  There are many potential covariates that 
are not included in the model because the data are not completely available across larger 
geographic areas.  Examples of other potentially contributing factors are the percent of 
adults that smoke, the percent of children exposed to second hand smoke and indoor 
allergens[61, 62], air pollution and outdoor allergen measurements[53, 63-71], obesity[69, 
71] and percent of children with insurance[72]. A second limitation is the simplicity of the 
calculation of the number of children with asthma, as described in the Methods. The age 
breakdowns used for each state are slightly different based on data availability. A third 
limitation is that we allow pediatric patients to be seen by adult specialists; access to 
specialist care would be even worse under the alternative. Standard limitations about 
regression apply to this study, where findings point to associations rather than to causality. 
Finally, we are using models to quantify potential access to care.  
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Taking these known limitations into consideration, the work in this chapter 
demonstrates there is a significant relationship between geographic access to both primary 
and asthma specialist care and severe pediatric asthma outcomes.  The results clearly 
indicate areas that can be targeted for interventions and an approach that can be applied to 
other states.  Finally, the framework presented can be extended to study the relationship 





CHAPTER 3. SPATIAL AND SEASONAL ACCESS TO 
PRIMARY AND SPECIALIST PEDIATRIC ASTHMA CARE 
3.1 Introduction 
Asthma is a chronic condition that affects people of all ages. In addition to impacting 
patients’ daily life, asthma can lead to severe health outcomes.  Both underlying severity 
of the disease and how well controlled the patient’s asthma is contribute to the likelihood 
of severe outcomes [9-11, 73].  
Receiving proper medical treatment is critical to controlling asthma; regular medical 
visits are recommended for most children to maintain control over their asthma.  Children 
who received specialist care for one year after diagnosis experienced a reduction in both 
asthma episodes and antibiotic use.[74]  There is also a significant decrease in asthma 
symptoms and emergency visits for patients within one year after their first visit to a 
specialist [75].  
National guidelines recommend 2 to 12 visits per-year for asthma care when a child 
has well controlled asthma, and even more frequent visits for those whose asthma is not 
well controlled [76].  However, recent research on longitudinal asthma care for about a 
million Medicaid-enrolled children diagnosed with persistent asthma found that the rate of 
physician office visits for asthma care is very low compared to the recommended care 
guidelines [77].  
Access to asthma care is a major determinant of healthcare utilization.  According to 
the Community Guide for Preventive Services, comprehensive multi-component, multi-
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trigger interventions for asthma care include appropriate access to clinical care [78]. Access 
to healthcare is associated with fewer disparities in health outcomes, reduced healthcare 
costs by preventing emergency care to treat preventable conditions, and improved quality 
of life [79, 80]. Prior research has showed that geographic access to specialist and primary 
care for asthma is a significant factor in estimating and predicting severe outcomes for 
pediatric asthma [81]. 
The aim of this chapter is to measure and make inference on accessibility and 
availability of pediatric asthma care at the community level, with comparison across 
multiple states. Availability is the opportunity patients have to choose among different 
providers of healthcare services, varying in the service quality and patient accommodation 
[82]. Accessibility is the time and/or distance barriers that patients experience in reaching 
their providers [82]. Spatial access, referring to availability and accessibility together [83-
85], is critical to manage chronic disease care such as pediatric asthma. 
Specific research questions include: 
• What healthcare providers provide pediatric asthma healthcare and what is their 
capacity devoted to asthma? 
• Are there seasonal differences in spatial access to pediatric care? 
• Are there systematic disparities in spatial access to pediatric asthma care between-
states?  
• Are there systematic disparities between children eligible for Medicaid/CHIP versus 
other children?  
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The states piloted in this analysis include seven southeastern states (Alabama, Arkansas, 
Georgia, Louisiana, Mississippi, North Carolina, and Tennessee). The selected states vary 
significantly in implementation of Medicaid/CHIP programs, as well as in population size, 
population distribution, and demographics but they share geographic proximity.  
3.2 Methods 
The data sources include 2005-2012 Medicaid Analytic eXtract (MAX) data files 
acquired from the Centers for Medicare and Medicaid Services (CMS), the National Plan 
and Provider Enumeration System (NPPES), Census Bureau and American Community 
Survey among others.  This study was approved by CMS (Data Use Agreement #23621) 
and by the Institutional Review Board of Georgia Tech (protocol #H11287). 
3.2.1 Study Population 
The study population consists of children ages 5 to 17 in the seven states. Children 
age 4 or younger are excluded from this analysis because of the difficulties in obtaining an 
accurate asthma diagnosis in young children.  We divide the child population into age 
groups: 5-9, 10-14, 15-17.  Children are also divided into groups based on insurance type.  
For ease of presentation, children that meet the eligibility criteria for public insurance 
(Medicaid/CHIP) are referred as Medicaid, and children that are not eligible for 
Medicaid/CHIP are referred as non-Medicaid. 
3.2.2 Demand Estimation 
For this project, we make the simplifying assumption that all of the population in a 
census tract is located at the centroid of the census tract.  Grouping patient locations by 
census tract ensures that the optimization model remains small enough to be solved directly 
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using Cplex.  The latitude and longitude coordinates for the centroid of each census tract 
based on the 2010 census are downloaded from the US Census Bureau website [86].  The 
demand is the number of appointments for asthma care demanded for children in each 
census tract.  Demand is differentiated into Medicaid and non-Medicaid visits, as well as 
primary and specialist care visits.   
The number of children in each age group is multiplied by the current asthma 
prevalence estimates from the Behavioral Risk Factor Surveillance System (BRFSS)[39] 
by the Centers for Disease Prevention and Control (CDC) to estimate the number of 
children with asthma in each census tract.   
3.2.2.1 Number of children with asthma per census tract  
We estimate the number of children with asthma in each census tract by combining 
publicly available data from the US Census with the Behavioral Risk Factor Surveillance 
System (BRFSS) survey data published by the Centers for Disease Control (CDC).   
For each state, census data table B09001 contains the number of children by age (5, 
6-8, 9-11, 12-14, 15-17) in each census tract and is downloaded from the US Census 
factfinder website [41]. 
Table C3 of the BRFSS Child Asthma Prevalence Tables provides the breakdown 
of lifetime and current asthma prevalence for each state by age (5-9,10-14,15-17) and is 
downloaded from the CDC website [39].   
The age groups used by the US Census and the CDC do not line up exactly, thus 
we adjust the breakdown of the census data to line up with the CDC age groups.  We add 
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together the number of children in each tract belonging to age groups 5 and 6-8, and one 
third of the children in age group 9-11 to obtain the number of children age 5-9.  We add 
together two-thirds of the children in age group 9-11 with the number of children age 12-
14 to obtain the number of children age 10-14.  All values are rounded up to the nearest 
integer number of children. The number of children age 15-17 does not need to be adjusted.  
We multiply the current asthma prevalence for a particular age group by the number of 
children of that age in each census tract to estimate the number of children with asthma per 
age group per census tract.  Finally, we take the sum across the three age groups to get the 
final estimate for the number of children with asthma per census tract. An example for one 
census tract, 9501, in Georgia is given below, with BRFSS data in Table 4, census 
population data in Table 5, and the estimates for the number of children with asthma in 
Table 6.   
Table 4: BRFSS Table C3: 2010 Current Asthma Prevalence for Georgia by age 
group 
% Kids 5-9 % Kids 10-14 % Kids 15-17 
13.7% 6.0% 10.9% 
Table 5: Population in Tract 9501 from Census Table B09001 and then aggregated 
to match BRFSS data age groups. 
# Kids  
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# Kids  
12-14 
# Kids  
15-17 
# Kids  
5-9 
# Kids  
10-14 
# Kids  
15-17 
40 247 181 90 97 348 211 97 
# Kids 5-9 = 40 + 247 + (1/3)*181 
# Kids 10-14 = (2/3)*181 + 90 
# Kids with Asthma 5-9 = 348*0.137 
# Kids with Asthma 10-14 = 211*0.06 
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# Kids with Asthma 15-17 = 97 * 0.109 
Table 6: Number of Children with Asthma in Georgia Tract 9501 
# Kids 5-9 # Kids 10-14 # Kids 15-17 # Kids 5-17 
46 13 11 72 
3.2.2.2 Number of visits needed in each census tract per season 
Asthma care guidelines state that children with well-controlled asthma should have 
a minimum of 2 visits per year for maintenance of their asthma management plan, and 
children with more severe or uncontrolled asthma should go to a physician up to twice a 
month until their asthma is considered to be well-controlled [73].  In the literature, 
however, many studies indicate that asthma is undertreated [13, 87-89]. 
Using the Medicaid MAX files, we determine the average number of asthma visits 
per year for children with asthma.  For each child in the population with asthma, we count 
the number of asthma (primary or secondary diagnosis code) visits he has each year.  The 
average number of asthma visits across all children with asthma in the seven states is 2.16 
visits per year.  It follows that for each census tract, we thus assume the number of asthma 
visits required each year to be 2 visits per child with asthma. While this is lower than we 
would expect based strictly on the asthma care guidelines, it is consistent with the 
understanding in the literature that many children receive insufficient care for their asthma.   
To divide the yearly visits by season, we use the Medicaid MAX files as defined 
below.  The percent of the annual visits that occur in each season is multiplied by the 
number of visits needed in each census tract, and the result is rounded up to the nearest 
visit. For example, we estimate that there are 72 children in Georgia census tract 9501 with 
asthma, each of which needs on average 2 visits per year for asthma care.  In Georgia, 47% 
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of asthma visits occur in the fall, 29% occur in the spring and 24% occur in the summer.  
The calculations for the number of visits needed per season are shown in full below. 
Fall Visits = 72 Children * 2 visits per year * 47
𝑉𝑖𝑠𝑖𝑡𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑎𝑙𝑙
100 𝑣𝑖𝑠𝑖𝑡𝑠 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟
 = 68 visits in the fall 
Spring Visits = 72 Children * 2 visits per year * 29
𝑉𝑖𝑠𝑖𝑡𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑎𝑙𝑙
100 𝑣𝑖𝑠𝑖𝑡𝑠 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟
 = 42 visits in the spring 
Summer Visits = 72 Children * 2 visits per year * 24
𝑉𝑖𝑠𝑖𝑡𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑓𝑎𝑙𝑙
100 𝑣𝑖𝑠𝑖𝑡𝑠 𝑝𝑒𝑟 𝑦𝑒𝑎𝑟
 = 35 visits in the 
summer 
3.2.2.3 Percent of children on Medicaid per census tract 
Census tracts are uniquely contained within county boundaries, so the county level 
percent of children on Medicaid can be applied to each census tract contained in that 
county.  We used the county level percentages from the Kids Count data center[90].  
Because we have assumed that each child demands the same number of asthma visits, the 
percent of children on Medicaid can be assumed to be the percent of visits for asthma care 
that are demanded by Medicaid patients.  For the model input, we then multiply the number 
of visits in each tract by the percent of the children in the tract that are on Medicaid.  This 
number is subtracted from the total visits needed to give the number of non-Medicaid visits 
per tract. 
3.2.2.4 Medicaid Asthma Visits Per Child  
From the 2005-2012 MAX claims data, we identify the Medicaid population that 
has asthma by selecting the patients with two or more claims with an ICD-9 code for asthma 
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(493.X).  For each Medicaid patient, we count the number of asthma care visits per-year. 
We assume that the average number of asthma visits per-year per Medicaid child is the 
same as the average number of asthma visits per-year per non-Medicaid child with asthma. 
The resulting Medicaid average of 2.16 asthma visits per-year is multiplied by the number 
of children with asthma in each census tract to obtain the number of asthma visits per-tract 
per-year.  This is a lower bound because asthma care guidelines recommend at least two 
visits per year for children with controlled asthma, and more for children with severe or 
uncontrolled asthma [73].   
We also compute the percent of Medicaid pediatric asthma visits occurring in each 
of the three seasons defined by the primary education academic calendar, Fall, Spring, and 
Summer.  These percentages are multiplied by the number of annual visits per-tract to 
obtain the number of pediatric asthma visits per-tract per-season.  The same number of 
visits per-year and percent of visits occurring in each season are used for all of the states.  
Appendix Table 1 contains additional data about the start and end times of each season. 
The demand for pediatric asthma visits is further split into demand for primary care 
visits and demand for asthma specialist visits.  We assume that 25% of children should be 
referred to an asthma specialist for care based on the prevalence of severe or uncontrolled 
asthma [91, 92] and expert opinion. 
3.2.3 Supply Estimation 
We consider two different categories of providers, primary care providers and 
asthma specialists.  The primary care providers include Pediatricians, Pediatric Nurse 
Practitioners, and Family Practice or Internal Medicine.  The group of specialist providers 
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includes (Pediatric) Allergists and (Pediatric) Pulmonologists. The exact NPPES taxonomy 
codes included are in Appendix A Table 37.   
3.2.3.1 Location of providers 
A complete list of medical providers in the United States is available in the National 
Provider Index files that are published each year through the National Plan and Provider 
Enumeration System (NPPES)[93] and contain each provider’s street address and 
taxonomy codes.  The set of providers with taxonomy codes for primary care and asthma 
specialists are extracted from the NPI files.  The street addresses of these providers are 
submitted to the Texas A&M Geoservices Batch Geocoding website [94] to obtain the 
corresponding latitude and longitude coordinates.   
3.2.3.2 Medicaid Acceptance 
Each asthma provider that has claims in the MAX database is marked as accepting 
Medicaid.  We assume that an individual provider either accepts Medicaid or not, and if a 
provider accepts public insurance then he will not reject any Medicaid patients unless his 
capacity is full. This assumption may overestimate access to pediatric asthma care for this 
sub-population. 
Each claim in the Other Therapy (OT) MAX files includes data elements that 
identify the billing and service providers, PRVDR_ID, NPI (corresponding to the 
PRVDR_ID) and SRVC_PRVDR_ID.  We extract the list of unique providers (we take the 
unique combination of PRVDR_ID, NPI, and SRVC_PRVDR_ID) that have any Medicaid 
claims with a primary or secondary diagnosis for pediatric asthma.  This set of providers 
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is independent from the provider list that is identified using the NPI and NUCC Taxonomy 
codes.   
There are many records that have missing or unknown values for the provider ID 
or different billing and service provider IDs, there is not a 1-1 matching of billing and 
service providers, and there is not a column in the database for the NPI corresponding to 
the service provider id directly.  In order to obtain the NPI for each service provider, we 
query the database using the values of SRVC_PRVDR_ID as the PRVDR_ID and extract 
the corresponding NPI value.  Unfortunately, there is not always a unique NPI for each 
service provider ID.  For the service providers that have two unique NPI values in the 
database but one is a code for an unknown NPI, the known NPI value is selected.  For 
providers with two or more distinct NPI codes that are not for an unknown NPI, we are 
unable to identify which NPI is correct. 
We add the NPI corresponding to each service provider, where available, to the 
asthma provider information so we have PRVDR_ID, NPI (for PRVDR_ID), 
SRVC_PRVDR_ID, NPI (for SRVC_PRVDR_ID).  For each line of provider information, 
we choose which NPI will be used to represent that row.  When the NPI for the service 
provider is available, it is selected, otherwise the NPI for the billing provider is used.  There 
are many providers with no NPI information for either the billing or service provider, these 
are labeled as “Unknown”.  This final list of NPIs is the set of providers that accept 
Medicaid for pediatric asthma visits.   
For each provider in the set of primary care and specialist physician identified using 
the NPI and NUCC Taxonomy codes, we check if their NPI is in the list of NPIs accepting 
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asthma patients in the MAX files.  In addition to the primary and asthma specialist 
providers that we know accept Medicaid patients, we select a random subset of additional 
primary and asthma specialist providers that we will allow to accept Medicaid to account 
for the Medicaid providers with an “Unknown” NPI.  For each state, we have P primary 
care providers that we know accept Medicaid, S specialist providers that we know accept 
Medicaid, and U Medicaid providers with an “Unknown” NPI value.  We randomly select 
PM additional primary care providers and SM specialist providers to accept Medicaid. 
where PM = 0.5*U*P/(P+S) and SM = 0.5*U*S/(P+S).  The number of providers selected 
to accept Medicaid is U/2 instead of U because in each state, many of the providers with 
an “Unknown” NPI have a taxonomy code that identifies them as labs, dentists, or other 
providers that would not qualify to provide pediatric asthma treatment, even though they 
see patients that also have pediatric asthma.  For the final data files, the number of randomly 
selected additional providers to accept Medicaid ranges from 54 (Arkansas) and 520 
(Mississippi). 
It is at this stage of the analysis that South Carolina was removed from 
consideration because of incomplete provider data in the MAX files.  The majority of 
asthma records did not have usable provider data (mostly missing NPI values) and so 
accurate provider capacity data could not be obtained. 
3.2.3.3 Caseload 
There are no standard values for what a physician’s maximum caseload is because 
this measure is dependent on so many factors.  Based on the caseload ranges in the 
literature, the Kaiser-Permanente average caseload for primary care and expert opinion, 
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this paper uses a caseload for primary care physicians of 1700 patients per-year and for 
specialists of 1200 patients per-year [95-97].   
We assume that each provider has a maximum percentage of his total visits that are 
used for pediatric asthma.  To estimate caseload for asthma, we use the 2012 MAX data to 
compute the percent of the Medicaid claims visits that were for pediatric asthma. These 
provider-level capacitates are further aggregated by provider type.  We then assume that 
the percent of Medicaid visits that is for pediatric asthma is the same as the percentage of 
a provider’s visit capacity that is for pediatric asthma. In order to account for variation 
between providers, we added a buffer to each individual provider’s capacity.  The 
additional percent of each provider’s capacity that is added is computed by sampling from 
the empirical distribution of provider capacities across all of the states, split by primary 
and specialist providers and into high (above the median) and low (below the median) 
capacities for asthma care.  10% of the sampled value is added to the physician’s percent 
capacity for asthma care. 
We assume that the capacity at each provider is uniformly distributed across the 
calendar year, so we compute the provider capacity in a particular season as the percent of 
their total capacity that occurs within the fraction of the year that belongs to that season.  
For example, there are 18 weeks in the fall season, so 18/52 = 34.6% of a provider’s annual 
capacity for asthma visits is available for asthma visits that occur in the spring. 
3.2.4 Access Optimization Model 
To estimate geographic access to asthma care, we use a centralized optimization 
model with a similar structure to the ones used by Nobles et al and Gentili et al. [31, 98].  
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Our mathematical formulation differs from the one presented by Gentilli et al. by including 
assignment to asthma specialists in addition to primary care providers, using a smoothing 
term in the objective function like the one presented by Zheng et al. [99] instead of 
balancing distance with provider congestion, and determining which patients will not 
receive care because of limited provider capacity instead of enforcing that a given 
percentage of visits will be assigned.   
The assignment decision variables represent the number of patient visits in each 
census tract, separated by whether or not they are in the Medicaid system, that are assigned 
to each primary or asthma specialist office.  These are 𝑥𝑖𝑗 and 𝑦𝑖𝑗 for non-Medicaid and 
Medicaid patients where i is a census tract and j is a provider.  We also have variables to 
track the percent of appointments that should ideally be assigned to a specialist but are 
instead assigned to a primary care provider for non-Medicaid visits (𝑣𝑖) and Medicaid visits 
(𝑤𝑖) for each census tract i.  Finally, we have variables to track with percent of 
appointments are not assigned at all (𝑔𝑖
𝑡) for each census tract i and physician type t (MD 
– primary care non-Medicaid, MDM – primary care Medicaid, S – specialist non-Medicaid, 
SM – specialist Medicaid). 
The objective function, shown in Figure 12, minimizes the sum of the total distance 
for the assignments that are made, the penalties for not assigning needed visits to a 
provider, and the weighted smoothing terms between each pair of census tracts.  The 
second term is necessary because there are places where there is insufficient provider 
capacity to meet the demand.   
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Figure 12: Optimization model objective function 
The smoothing terms are a practical restriction on the system to prevent children in 
neighboring census tracts to have dramatically different assignments or average distances 
to care.  Two census tracts are considered to be neighbors if the distance between their 
centroids is less than 10 miles.  In the optimization model, we penalize differences in the 
average distance per visit to a particular provider type between neighboring census tracts.  
Without this smoothing term, it is possible for the model to assign all of the children in one 
census tract to a provider and none of the children in a neighboring tract, where the more 
realistic outcome would be that half of the children in each tract would visit the provider.   
Some children with asthma should receive asthma care from a specialist instead of 
solely relying on a primary care provider, and so we include a separate sets of decision 
variables for the assignment of patient visits to primary and asthma specialist providers.  
The capacity at each provider location for asthma visits depends on the provider type and 
number of physicians, as described in the supply section.  For this subset of asthmatic 
children that should receive specialist care, it is possible that they receive some, or all, of 
their treatment from primary care providers and so we allow for the assignment of these 
visits to primary care providers with a penalty to account for the preference that the visits 
be made to a specialist.  For every non-Medicaid visit that is assigned to a primary care 
provider instead of a preferred specialist, there is a penalty of 15 miles added to the 
assignment distance, and for Medicaid patients the penalty is 20 miles.  We impose a higher 
penalty for Medicaid patients because this population is already underserved and faces 
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greater transportation restrictions, so are less likely to be able to travel farther to receive 
specialist care than non-Medicaid patients.  With these penalties, a patient would have no 
preference between a specialist that is 50 miles and a primary care provider that is 35 miles 
away.  This accounts for patient preference to have a closer provider, and allows children 
who do not have access to a specialist at all to be assigned to a primary care provider.   
Another practical constraint that we add to the model is that for each census tract 
the average distance for visits to a particular provider type that are by children on Medicaid 
cannot be lower than the average distance for non-Medicaid visits in the same tract.  This 
ensures that we do not assign only the Medicaid patients when there is insufficient capacity. 
This model is solved for each of the three seasons for each state.  This allows the 
results to be compared across the seasons for each state, and between the states.  The list 
of sets and parameters are given in Table 6 and Table 7, and the constraint set for the 
mathematical model is given in Figure 13 below. 
Table 7: Set notation and descriptions 
Set Description 
D The set of all providers 
𝐷𝑃 The set of primary care providers 
𝐷𝑆 The set of specialist providers 
𝐷𝑡𝑦𝑝𝑒 The set of physician types (MD, MDM, S, 
SM) 
T The set of census tracts 
Table 8: Parameter notation and descriptions 
Parameter Description 
𝑎𝑖
𝑛 the number of non-Medicaid appointments needed in tract i 
𝑎𝑖
𝑚 the number of Medicaid appointments needed in tract i 
r the percent of appointments that should be met by a specialist 
rMin the percent of appointments that should be met by a specialist that 
must be met by a specialist 
nr the percent of appointments that should be met by primary care 
physicians (1-r) 
𝑑𝑖𝑗 the distance (miles) from the centroid of census tract i to provider j 
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Parameter Description 
𝑞𝑖𝑗 binary value for if provider j accepts Medicaid patients 
𝑢𝑖𝑗 the capacity, in appointments, of provider j 
p the penalty, in miles, for not assigning 1 appointment to a provider 
at all 
𝑝𝑎 binary value for if census tracts k and j are neighbors or not 
𝑛𝑖𝑘 the distance, in miles, between the centroids of tracts i and k 
𝑑𝑖
𝑡 the average distance for appointments to physician type t in tract i 
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3.2.5 Access Measures 
(1) The travel distance measured as the average distance to receive care; 
(2)  The unmet need for asthma specialists measured as the percent of visits that are 
assigned to primary instead of specialist care; and 
(3) The unmet need for asthma care measured as the percent of visits that cannot be 
assigned to a provider within the Georgia access standards (30 miles in urban and 
45 miles in rural communities).   
The access measures are computed for the four provider categories (MD, MDM, S, SM) 
at the census tract level.   
The measure for unmet need includes those visits that cannot be assigned by the 
optimization model because there is insufficient provider capacity in the state as well as 
the visits that are assigned to a provider that is more than 30 or 45 miles away for urban 
and rural children.  We use the same access standards for all seven states for consistency 
in the analysis.  Alabama, Arkansas, Louisiana, and North Carolina do not have access 
guidelines, and the distance cut-offs for Georgia, Mississippi and Tennessee range from 8 
to 30 miles for urban primary care and 45 to 90 miles for rural specialist care [100]; see 
Appendix A Table 38. 
3.2.6 Statistical Analysis 
The primary statistical tests are one-way ANOVA to determine if we can reject the 
null hypothesis that the mean of a given measure is the same in all states or seasons, and 
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the pairwise Tukey’s Test to identify which of the pairs are different.  These tests are 
applied to the available provider capacity, the distance to receive care, and the unmet need. 
To compare the results of the optimization model across the seasons, we use the 
null hypothesis of equal means in all three seasons.  This test is used for each state and 
provider type for the Medicaid and non-Medicaid population to determine if there are 
seasonal differences in the access measures.  In addition, we test the null hypothesis that 
the distance to receive a particular type of care (MD, MDM, S, SM) is the same across all 
states in the fall season.   
We compare the unmet need in each state using the null hypothesis that the unmet 
need in each state is the same to determine if there are significant differences in the number 
and percent of children that are not able to receive any asthma care. 
In order to determine the significance of the difference in access to the different types 
of care within each state, paired t-tests are used to compare the distance to receive care 
between pairs of provider types (MD-MDM, S-SM, MD-S and MDM-SM).  We repeat 
these tests for the null hypothesis of equal means and then for a difference in means of 2, 
5, and 10 miles. 
3.3 Results 
3.3.1 Supply Estimation: Pediatric Asthma Caseload by Provider Type  
Only a fraction of each physician’s total caseload will be dedicated to pediatric 
asthma visits.  For each provider in the OT MAX files that accepts Medicaid patients, we 
extract their caseload summary.  We count the number of distinct patients that they serve 
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each year, the number of distinct children with asthma that they serve each year (see 
demand section for more details on this population), the total number of visits (where 
claims occurring at the same place of service on the same day are counted as one visit) that 
are recorded each year, and the total number of visits where the primary or secondary 
diagnosis code is for asthma and the patient is a child age 5-17.  The percent of the 
provider’s caseload for pediatric asthma is the number of distinct asthma children divided 
by the total number of patients, and the percent of their visits that are for pediatric asthma 
is the number of pediatric asthma visits divided by the total number of visits.  
The average percent of the provider’s caseload and the average percent of visits 
that are for pediatric asthma are computed for each provider type (Pediatrician, Pediatric 
Nurse Practitioner, Family and Internal Medicine, Pulmonologist, Allergist, Pediatric 
Pulmonologist, Pediatric Allergist) using the same formulas as those for individual 
providers.  Figure 14 below shows the boxplots of the percent of provider visits that are for 
pediatric asthma by provider type and states.  
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Figure 14: Distribution of the assigned tract level distance to primary and asthma 
specialist care for Medicaid and non-Medicaid patients in each state for the fall 
season with clearly increasing trend by provider type.  For the provider type 
abbreviations, we have non-Medicaid and Medicaid primary care (MD & MDM) 
and non-Medicaid and Medicaid specialist care (S & SM)   
The percent of a provider’s visits in each state summarized by provider type is in 
Table 9.  The percent of the Medicaid caseload for primary care physicians for children 
with asthma is consistent across all of the states.  Between 2 and 5% of patients at a 
pediatrician’s office have asthma, between 1 and 3.5% of patients have asthma at both 
family practices and internal medicine providers, and between 3 and 8.3% of patients that 
see a pediatric Nurse Practitioner have asthma.   
In Alabama, pediatric pulmonologists have the highest percentage (54.7%) of 
pediatric asthma patients, followed by non-pediatric allergists and pulmonologists (19% 
and 18%).  In Arkansas, the only provider category with more than 7% of their panel 
belonging to children with asthma is non-pediatric allergists, who have on average 46% 
pediatric asthma patients.   
Table 9: Percent of provider visits in the MAX claims files that are allocated for 

























































































































































AL 1.5% 2.4% 4.6% 1.4% 1.9% 1.6% 25.7% 63.2% 19.9% -- 25.8% 
AR 0.7% 1.3% -- 0.5% 0.7% 0.5% 0.2% -- 55.1% 8.3% 7.6% 
GA 1.0% 1.6% 2.6% 1.2% 1.4% 1.3% 2.6% 34.8% 14.2% 42.6% 18.2% 
LA 0.8% 0.75% 0.8% 0.6% 0.6% 0.6% 0.7% 26.5% 19.2% 1.1% 1.3% 
MS 0.8% 1.7% 1.9% 1.2% 1.1% 1.2% -- -- -- -- -- 
NC 0.8% 1.1% 4.1% 0.5% 0.7% 0.6% 0.5% 1.2% 21.0% 10.7% 3.5% 
TN 0.9% 1.2% 4.5% 0.9% 0.8% 0.9% 0.7% 17.1% 7.5% 22.7% 5.3% 
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To account for the variation in provider capacity and percent of their caseload and 
visits that are used for pediatric asthma, we add a random, non-negative buffer capacity to 
the percent of their caseload and visits that are available for pediatric asthma.  For every 
provider, we add a buffer capacity that is based on the empirical distributions of the percent 
of patients and visits that are used for pediatric asthma among the Medicaid providers.  The 
data for all seven states is combined into one set for this analysis.  Among primary care 
providers, the percent of the caseload and visits for pediatric asthma are very similar across 
the states, so combining the states data does not have a significant impact on the 
distributions.  For specialist providers, we need to take all of the states and providers 
together in order to have a sufficiently large group of providers to create a distribution to 
sample from.  
This sampling is done separately for primary care, specialist care, percent of the 
patient caseload and percent of the patient visits that are for pediatric asthma.  The process 
is described below for the percent of the patient caseload at primary care providers, and is 
repeated for the three other cases. 
Using the R statistical software package, we compute the summary statistics for the 
percent of the patient caseload that is for asthma patients at primary care providers and then 
split the data set into two groups.  The High Capacity group contains the data for providers 
whose percent of the caseload is greater than the median percent (M%), and the Low 
Capacity group contains the data for providers whose percent of the caseload is less than 
the median percent.  We fit an empirical distribution to the percent of the caseload for the 
high and low capacity groups separately.   
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For each primary care provider in the set identified using the NPI and NUCC 
Taxonomy codes, we classify the provider as high or low capacity by comparing their 
baseline percent of the patient caseload to the median percent, M% as identified above.  
There are NP_H primary care providers that are high capacity and NP_L primary care 
providers that are low capacity.  We take NP_H samples (𝑠𝑖
𝐻 with i from 1 to NP_H), with 
replacement, from the High Capacity distribution and NP_L samples (𝑠𝑗
𝐿 with j from 1 to 
NP_L), with replacement, from the Low Capacity distribution.  For each high capacity 
primary care provider i (with i from 1 to NP_H) we add 𝑠𝑖
𝐻*0.1 to their baseline capacity, 
and for each low capacity primary care provider j (with j from 1 to NP_L) we add 𝑠𝑗
𝐿*0.1 
to their baseline capacity.  The distribution of the percent of visits for pediatric asthma for 
high and low acceptance primary care and specialist physicians are shown in Figure 15. 
 
Figure 15: Distributions of the percent of asthma visits each provider allocates for 
pediatric asthma by provider type 
In the optimization model, Family Practice and Internal Medicine are treated as one 
provider type.  This does not result in a loss of input data accuracy because the percent of 
a provider’s caseload and visits that are for pediatric asthma are very similar for these two 
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provider types.  For example, in Georgia the percent of the Medicaid caseload for children 
with asthma is 2.45% and 2.79% for Family and Internal Medicine respectively, and their 
percentage of visits that are for pediatric asthma are 1.23% and 1.4%.   
This consistency is not seen in the patient caseload of specialists.  In most states, 
non-pediatric pulmonologists do not have a large percentage of children with asthma in 
their panel (between 1 and 5%), but in Alabama almost 20% of the total Medicaid patients 
in a non-pediatric pulmonologist’s office are children with asthma.  For pediatric 
pulmonologists, North Carolina has an unusually low percentage, less than 2%, most of the 
states have 20-30%, and AL again has the highest rates with almost 55% of the patient 
panel being comprised of children with asthma.  In four of the states, 15-20% of allergist 
patients have pediatric asthma, two states have roughly 27%, and Arkansas stands out with 
40% of the panel being pediatric asthma patients.  Pediatric allergists have more variation 
in the percent of the panel that is children with asthma, with Arkansas having only 6.4% 
while Georgia has 43.4%.   
We assume that the percent of a provider’s non-Medicaid caseload that is for 
pediatric asthma visits is the same as the percent of that provider’s Medicaid caseload that 
is for pediatric asthma.  For primary care and specialist providers that we know accept 
Medicaid, we use their exact percent of Medicaid patients and visits that are for pediatric 
asthma as their base acceptance.  Since not all providers can be matched to one that accepts 
Medicaid patients, the average percent for each provider type (based on the Medicaid 
claims) is used as the percent of their visits that are available for pediatric asthma. 
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3.3.2 Geographic Variations in Supply 
There is significant geographic variation in the supply of primary and specialist 
visits both within each state and between the states.  The highest concentration of available 
visits occurs in urban areas, with fewer visits available in rural areas.  Every state has more 
zip codes with available primary care visits than zip codes with available specialist care 
visits.  Arkansas has the lowest percent of zip codes with available primary care visits 
(33%) and specialist care visits (5%).  Georgia and North Carolina have the highest percent 
of zip codes with available primary care visits (59% and 60%), and Georgia, Mississippi 
and North Carolina have the highest percent of zip codes with available specialist care 
visits (14%, 15%, and 15%).  Mississippi has the largest variance in the number of available 
primary care visits at the zip code level in one state, and Tennessee has the largest variance 
in the number of available specialist visits at the zip code level in one state.  Table 10 below 
shows the number of zip codes in each state that have any primary and specialist care visits 
available. 




of Zip Codes 
Zip Codes with Available 
Primary Care Visits 
Zip Codes with Available 
Specialist Visits 
AL 645 315 80 
AR 596 199 30 
GA 735 437 100 
LA 516 251 45 
MS 424 202 64 
NC 808 485 121 
TN 631 327 65 
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The number of visits for primary and specialist care differ significantly from state 
to state.  Table 11 contains the summary statistics for the number of primary and specialist 
visits available in each state, and Figure 16 shows the number of visits per zip code in each 
state.  Using ANOVA, we reject the null hypothesis that the number of appointments at the 
zip code level is the same in all seven states for both primary care and specialist visits (p < 
0.01 for both provider categories).  The differences in available tract level primary care 
visits between Mississippi and each of the other six states are all statistically significant 
(Tukey’s Test p-value < 0.01), while for specialist care visits the only state with which 
Mississippi differs significantly is Louisiana.  Tennessee has the only other significant 
differences in the number of specialist visits in the pairwise comparison with four states: 
Alabama, Georgia, Louisiana and North Carolina.   
Table 11: Summary statistics for the number of annual available visits for primary 
and specialist care across the zip codes in which there is at least one provider (either 
primary or specialist) by state 
 Available Primary Care Visits Available Specialist Visits 
 Min. Mean Max. Stdev Min Mean Max Stdev 
AL 3022 76,970 2427000 175559 0 26930 2033000 138439 
AR 0 34070 636900 72828 0 31580 2259000 193675 
GA 0 64850 2229000 156234 0 30430 1269000 99677 
LA 0 54040 2259000 153206 0 3096 152700 14456 
MS 0 147800 1748000 238760 0 59460 2154000 199244 
NC 1984 62170 1425000 134034 0 30960 1441000 131500 






Available Primary Care Visits by Zip Code 
 
Available Specialist Visits by Zip Code 
 
Figure 16: Number of specialist visits available for primary and specialist care in 
each zip code. Zip codes that are shaded in black have no providers. 
3.3.3 Access Measures: Travel Distance 
Figure 17 shows the boxplots of the tract-level travel distance to receive care for all 
states and provider types, for the Medicaid and Non-Medicaid population, in the Fall 




Figure 17: Distribution of the assigned tract level distance to primary and asthma 
specialist care for Medicaid and non-Medicaid patients in each state for the fall 
season with clearly increasing trend by provider type. 
For all states except Tennessee, the MD median tract-level distance is the lowest, 
followed by the distance for MDM visits, followed by distance to S visits, with the largest 
distances being for SM visits.  In Tennessee, the order is inverted for MDM and S median 
distances.  
The distribution of the tract-level distances for MD visits are similar across all of 
the states, with the differences in distance between the states being more pronounced for 
MDM visits.  There is more variation in the distance to asthma specialists than to primary 
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care providers, and the greatest differences between the states occur when considering the 
driving distance for SM visits.   
The median distance to specialist care is at least twice as high for the Medicaid 
population as it is for the non-Medicaid population in every state.  In addition, the inter-
quartile range of the tract-level distance to care is larger for SM visits than for any other 
type of care in all states.  
Based on the ANOVA results, the difference in the distance to receive care in the 
different seasons is not statistically significant (p-value < 0.05) for most states and provider 
types.  The cases where the travel distances to receive care are statistically different are for 
the Medicaid/CHIP-enrolled children for access to primary care in North Carolina and 
Tennessee, and to specialist care in Tennessee.  
ANOVA confirms that the distance to receive each type of care is not the same in 
all of the states.  The differences between the tract-level distances between the states are 
significant with p <2e-16 for all four provider types.  From the Tukey’s Test results we see 
that only 12 of the 21 state pairs have significant differences in distance to MD visits, and 
17 pairs have significant differences in distance to MDM visits.  For specialist care there 
are 17 and 18 pairs with significant differences in the distance for S and SM visits 
respectively.  contains the mean difference in distance and the p-values for each provider 




Table 12: Tukey’s Test results comparing the mean tract level distance, in miles, 
between each pair of states to receive each of 4 types of care  
 MD MDM S SM 
State 
Pair 









AR-AL -0.05 1.0000 2.83 0.0000 2.75 0.0000 -3.65 0.0005 
GA-AL -0.84 0.0000 -1.26 0.0000 -3.53 0.0000 -12.05 0.0000 
LA-AL -0.65 0.0007 -1.98 0.0000 -2.13 0.0000 -13.05 0.0000 
MS-AL 0.06 0.9999 -3.34 0.0000 1.82 0.0018 -12.53 0.0000 
NC-AL -1.00 0.0000 -0.41 0.6563 -1.80 0.0000 -7.34 0.0000 
TN-AL -0.70 0.0000 0.12 0.9994 -2.79 0.0000 -10.46 0.0000 
GA-AR -0.79 0.0000 -4.09 0.0000 -6.28 0.0000 -8.40 0.0000 
LA-AR -0.60 0.0177 -4.81 0.0000 -4.88 0.0000 -9.40 0.0000 
MS-AR 0.11 0.9983 -6.17 0.0000 -0.93 0.5787 -8.88 0.0000 
NC-AR -0.95 0.0000 -3.25 0.0000 -4.56 0.0000 -3.69 0.0001 
TN-AR -0.65 0.0023 -2.71 0.0000 -5.54 0.0000 -6.81 0.0000 
LA-GA 0.19 0.8097 -0.72 0.1060 1.40 0.0030 -1.00 0.5918 
MS-GA 0.90 0.0000 -2.08 0.0000 5.35 0.0000 -0.49 0.9901 
NC-GA -0.15 0.8176 0.85 0.0018 1.73 0.0000 4.71 0.0000 
TN-GA 0.14 0.9261 1.38 0.0000 0.74 0.2675 1.59 0.0286 
MS-LA 0.70 0.0022 -1.36 0.0018 3.95 0.0000 0.51 0.9929 
NC-LA -0.35 0.1516 1.56 0.0000 0.33 0.9741 5.71 0.0000 
TN-LA -0.06 0.9998 2.10 0.0000 -0.66 0.6283 2.59 0.0004 
NC-MS -1.05 0.0000 2.92 0.0000 -3.63 0.0000 5.19 0.0000 
TN-MS -0.76 0.0002 3.46 0.0000 -4.61 0.0000 2.08 0.0399 
TN-NC 0.29 0.2034 0.54 0.2475 -0.98 0.0383 -3.12 0.0000 
Within each state, we have significant differences in the distances to receive 
different types of care. For each state, we perform paired t-tests to compare the tract level 
distance to receive each type of care within the state and determine at which threshold 
(unequal means, difference of 2 miles, 5 miles, or 10 miles) is the difference in the distance 
care is significant.  Table 13 below gives the maximum distance threshold (0 miles, 2 miles, 
5 miles or 10 miles) at which the difference between the distance to different types of care 
is significant.  Table 14 below contains the mean difference in the distance to care for each 
pair of provider types in each state, as well as the p-values indicating the significance, or 
lack thereof, of the difference in distance for provider types at each threshold. 
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Table 13: Maximum distance at which the difference between the distance to two 
types of care is significant.  The distance to the provider type listed second in each 
pair is the greater distance.  Ex: MD-MDM tests if the MDM distance is greater 
than the MD distance by the threshold distance value. 
State/Provider 
Types MD-MDM S-SM MD-S MDM-SM 
AL 2 10 5 10 
AR 5 10 5 10 
GA 5 5 2 5 
LA 2 2 2 5 
MS 0 0 5 5 
NC 2 10 5 10 
TN 2 5 2 5 
Table 14: Mean difference in distance to receive care to selected pairs of provider 
types and p-values for paired t-tests indicating if the difference in distance to care is 
significant at the given threshold. 
 AL AR GA LA MS NC TN 
MD-MDM Diff Mean 
Value 
-4.01 -6.94 -3.46 -5.23 -1.52 -4.51 -4.72 
MD-MDM Diff 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
MD-MDM Diff > 2 0.0000 0.0000 0.0000 0.0002 1 0.0000 0.0000 
MD-MDM Diff > 5 1 0.0000 1 1 1 1 0.9762 
MD-MDM > 10 1 1 1 1 1 1 1 
S-SM Diff Mean Value -17.67 -11.86 -7.55 -5.04 -8.46 -10.94 -8.59 
S-SM Diff 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
S-SM Diff > 2 0.0000 0.0000 0.0000 0.0000 0.9931 0.0000 0.0000 
S-SM Diff > 5 0.0000 0.0000 0.0000 0.2092 1 0.0000 0.0000 
S-SM Diff > 10 0.0000 0.0061 1 1 1 0.0003 1 
MD-S Diff Mean Value -6.81 -9.39 -4.23 -7.54 -8.46 -5.91 -4.68 
MD-S Diff 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
MD-S Diff > 2 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
MD-S Diff > 5 0.0000 0.0000 1 0.4346 0.0000 0.0000 0.9517 
MD-S Diff > 10 1 0.9090 1 1 0.9998 1 1 
MDM-SM Diff Mean 
Value 
-19.62 -12.71 -8.25 -0.57 -9.44 -11.88 -4.68 
MDM-SM Diff 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
MDM-SM Diff > 2 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
MDM-SM Diff > 5 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 




Figure 18: County level distance for primary and specialist appointments for 
Medicaid and non-Medicaid patients.  Counties shaded with black have no met need 
(the optimization model is unable to assign any visits to providers in these counties). 
3.3.4 Access Measures: Unmet Need for Specialist Care 
In every state and season, the percent of appointments that were assigned to primary 
care providers instead of specialist providers is higher among the Medicaid population than 
the non-Medicaid population.  The maximum percent of visits in an individual tract that 
are assigned to primary instead of specialist care is higher for the Medicaid population in 
every state except for North Carolina.   
Table 15 provides the number of tracts where all of the specialist appointments are 
met by primary care providers in each state.  For example, in Arkansas, over 20% of the 
census tracts (149 of the 686 tracts) have all of the appointments that were allocated for 
SM care assigned instead to MDM providers; for the non-Medicaid population, there are 
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only 9 tracts where the entire demand for specialist appointments is assigned to primary 
care providers.   
Table 15:  Number of census tracts in which all specialist appointments are met 
instead by primary care providers for both the Medicaid and non-Medicaid 
population 
State # Census Tracts 
# Tracts All S visits 
assigned to MD 
providers 
# Tracts All SM visits 
assigned to MDM 
providers 
AL 1181 1 138 
AR 686 9 149 
GA 1969 0 10 
LA 1148 7 20 
MS 664 0 0 
NC 2195 4 60 
TN 1497 1 16 
3.3.5 Access Measures: Unmet Need 
The percent of the need that is unmet in each season is almost the same; this means 
there is more unmet need in terms of visit number in the fall than in either the spring or the 
summer for both primary and specialist care in every state.  In Alabama, for example, there 
are over 1100 more visits that cannot be assigned to a Medicaid specialist provider in the 
fall than in the summer out of the 17000 more visits (for all provider types) that are 
demanded.  In Arkansas, 630 of the additional 11000 visits for Medicaid patients to receive 






Table 16: Unmet need in each state reported as the number and percent of visits 










State # % # % # % # % 
AL 244 5.5% 181 8.5% 1283 1.8% 2629 7.8% 
AR 225 4.8% 275 5.2% 341 2.1% 1825 10.3% 
GA 44 0.7% 360 4.9% 206 0.1% 3514 3.2% 
LA 56 5.4% 88 5.6% 648 1.9% 2711 4.6% 
MS 141 2.8% 73 2.7% 1056 2.1% 757 3.1% 
NC 327 5.5% 394 8.6% 844 1.0% 3256 5.2% 
TN 30 1.7% 191 10.3% 517 0.8% 1648 3.3% 
Table 16 shows a lower bound for the unmet need for each state in the Fall season 
divided by the urban and rural population.  The results for the spring and summer are 
similar.  Children on Medicaid have from 1.7 (Arkansas) to 5 (Mississippi) times as much 
unmet need for specialist care as for primary care.  There is more variation in the difference 
in unmet need for specialist care between the Medicaid population and the non-Medicaid 
population, ranging from Mississippi, which has slightly more unmet need in the non-
Medicaid population, to Georgia, where there is 20 times as much unmet need in the 
Medicaid population.  Table 17 summarizes the unmet need by provider type for the seven 
states and shows the ratio of unmet need between selected provider type pairs. 
In at least 1% of the census tracts in each state, all of the need for primary care, 
specialist care, or both, is unmet.  Arkansas has the worst access for Medicaid children 
requiring specialist care, with all of the need being unmet in 40% of the tracts.  This is 
distantly followed by 23% and 17% of tracts in Alabama and Louisiana having entirely 
unmet need for Medicaid specialist visits.  Arkansas is also only one of two states, 
Louisiana being the other, where none of the need for children on Medicaid for primary 
care is met in more than 10% of the census tracts.   
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The unmet need for non-Medicaid visits in rural areas is the highest in Alabama, 
Louisiana and Mississippi with over 5.4%.  For rural Medicaid children, Tennessee has the 
highest unmet need with 10.3% of the visits being unassigned under 45 miles.  In urban 
areas, the greatest unmet need occurs in Arkansas and Mississippi where 2.1% of non-
Medicaid visits cannot be assigned.   As in rural areas, access is worse for the Medicaid 
population in urban areas, and with unmet need reaching 10.3% in Arkansas. For both 
urban and rural areas, Georgia has the lowest unmet need for children that are not part of 
the Medicaid population, and is second lowest for unmet need for Medicaid visits. 
Table 17: Unmet need by provider type in each state and the ratio of unmet need for 
selected service types (ex: SM/S is the ratio of unmet need (as visits) for Medicaid 
specialist care to non-Medicaid specialist care) 
Number 
of Visits 
MD MDM S SM ALL MEDICAID 
ALL NON-
MEDICAID 
AL 406 714 524 2494 3208 930 
AR 172 960 153 1647 2607 326 
GA 133 1309 182 3788 5097 315 
LA 107 474 380 2164 2638 488 
MS 312 134 831 670 804 1142 
NC 365 953 433 3088 4041 798 
TN 118 398 334 1640 2038 453 
Ratios MDM/MD SM/S SM/MDM S/MD 
MEDICAID/NON-
MEDICAID 
AL 1.76 4.76 3.49 1.29 3.45 
AR 5.57 10.74 1.72 0.89 8.01 
GA 9.87 20.80 2.90 1.37 16.19 
LA 4.41 5.69 4.57 3.54 5.41 
MS 0.43 0.81 4.99 2.67 0.70 
NC 2.61 7.14 3.24 1.19 5.07 
TN 3.36 4.91 4.12 2.82 4.50 
Using ANOVA, we fail to reject the null hypothesis that the mean tract-level unmet 
need for rural primary care for both Medicaid and non-Medicaid is the same in all states.   
The full ANOVA output is in Table 18 below. We do reject the null hypothesis of equal 
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means for unmet need for rural specialist care and to both primary and specialist care for 
Medicaid and non-Medicaid patients in urban areas (F-Statistic <0.01).   
Table 18: ANOVA Results for percent of visits that cannot be assigned to a provider 
within an acceptable distance 
    Df Sum Sq Mean Sq F value Pr(>F) 
MD Urban 
State 6 5.95 0.99 69.00 <2e-16 
Residuals 8639 124.15 0.01     
MDM 
Urban 
State 6 6.19 1.03 51.21 <2e-16 
Residuals 8639 174.04 0.02     
S Urban 
State 6 2.44 0.41 29.52 <2e-16 
Residuals 8639 118.91 0.01     
SM Urban 
State 6 7.14 1.19 55.66 <2e-16 
Residuals 8639 184.73 0.02     
MD Rural 
State 6 0.23 0.04 1.94 0.0717 
Residuals 687 13.29 0.02     
MDM 
Rural 
State 6 0.10 0.02 2.00 0.064 
Residuals 687 5.93 0.01     
S Rural 
State 6 0.51 0.09 5.29 2.38E-05 
Residuals 687 11.07 0.02     
SM Rural 
State 6 1.53 0.26 4.66 0.0001 
Residuals 687 37.67 0.05     
Because there are statistically significant differences between the states, we use 
Tukey’s Test to identify which pairs of states have significant differences.  Appendix B.5 
provides the results of the statistical tests to determine for which pairs of states the 
difference in unmet need is significantly different for each provider type in rural and urban 
settings.  Significant differences have p-values that are highlighted in green.  
For rural non-Medicaid specialist care, the only significant differences between 
states are for Georgia when compared to Alabama and Arkansas.  For rural Medicaid 
specialist care, Alabama differs significantly from Georgia, Louisiana, and Mississippi.  11 
of the 21 pairs of states differ significantly in unmet need for urban Medicaid and non-
Medicaid primary care.  For urban specialist care, there are 9 pairs that differ significantly 
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for both Medicaid and non-Medicaid unmet need, and 3 additional pairs having different 
unmet need for non-Medicaid care, and 7 pairs with significantly different unmet need for 
Medicaid specialist care.   
3.4 Discussion 
This paper focuses on measuring and evaluating access to pediatric asthma care with 
comparison across multiple states. In contrast to prior models for measuring spatial access 
to pediatric asthma care that focus on one aspect of access such as travel time to a 
hospital[101] or provider to population ratio [25] or are based on interviews[102], or have 
a more limited constraint set [81], the measurement and inference approach in this study 
takes into account multiple aspects of the pediatric asthma healthcare: (1) Demand for 
asthma care is not constant over the course of a year; (2) Not all providers accept public 
(Medicaid/CHIP) insurance; (3) Pediatric asthma healthcare is provided by both 
specialized and primary care providers; and (4) A proportion of children have severe 
asthma and thus they need access to specialist care in order to control their condition. 
The capacity allocated to pediatric asthma among primary care physicians is 
consistent, with only small variations across providers and states.  Thus, the assumption 
that the capacity for non-Medicaid children with asthma among primary care physicians is 
similar to that for Medicaid population is reasonable.  
However, there is more variation in the percent of providers’ capacity for pediatric 
asthma among the specialists as inferred from the Medicaid claims.  In some cases, there 
are no providers or only one provider of a particular type that accept Medicaid in an entire 
state.  For example, in Alabama there are no Medicaid-accepting pediatric allergists, and 
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only one adult pulmonologist and one pediatric pulmonologist.  The caseloads for the adult 
(allergist and pulmonologist) and pediatric specialists are over 20% and 60% respectively, 
which may be because these providers have high asthma caseloads to meet the demand.  In 
Arkansas, on the other hand, it is the regular allergists with the larger asthma caseload of 
55%, while the pediatric allergists take less than 10% and the one pulmonologist accepting 
Medicaid has less than 1% of their visits for pediatric asthma.  These differences highlight 
that the asthma caseload is not strictly dependent on the number of specialists in a state nor 
the provider type.  While our constraints account for this variation by building in buffer 
capacity based on regional averages for the supply at each provider, they could be improved 
if caseload data for the non-Medicaid population at each provider location could be 
obtained.  There are many factors that may contribute to the variation in this capacity across 
provider types and states including prevalence of other conditions and number of providers 
available for both the Medicaid and non-Medicaid populations. 
There are not significant differences in spatial access to care between the seasons in 
spite of the variations in demand from one season to the next.  This means that in the areas 
where there is access to care, it is available all year long and that the capacity is high enough 
to handle the seasonal variations in demand.  On the other hand, there is unmet need even 
during the lower demand seasons indicating that in some areas, the reduced access to care 
is primarily driven by the lack of providers rather than the lack of provider availability as 
during busier times of the year. These results suggest that seasonal interventions such as 
school based programs may not be sufficient to provide access to asthma care, because 
more permanent and year-long interventions, such as adding to the care network additional 
asthma specialized providers, are needed for children to receive the treatment they need. 
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There is not one state that has the highest or lowest median distance to receive care 
in all four categories (Louisiana is the closest, with one of the lowest median distances in 
every category). This indicates that there is not one state that is entirely the best or the 
worst place to receive asthma care in terms of travel distance.  Rather each state has 
different areas with the greatest potential for improvement.  For example, Arkansas has 
one of the highest median distances to care for all categories, exceeded only by the median 
distance for Medicaid Specialist care in Alabama.  Therefore, we expect that Arkansas has 
one of the greatest potentials for improved access to care if the capacity for asthma visits 
were increased.   
Consistently across all of the states, the distance to receive care is the highest for the 
Medicaid population requiring specialist care.  This group also has the greatest variance in 
their distance to receive care within each state.   
Within each state, the assigned distances for specialist and Medicaid visits are higher 
than for primary care and non-Medicaid visits.  When comparing the distance to MD and 
MDM visits, the paired t-tests show that for every state except Mississippi the difference 
is either 2 or 5 miles farther for Medicaid than non-Medicaid visits.  The results are similar 
for the difference in the distance to MD and S appointments, with all state having a 
significant difference of 2 or 5 miles.  Georgia is the only state for which the difference in 
distance between MD and S visits is smaller than that between MD and MDM visits.  There 
are greater disparities when considering the distance to S and SM visits and MDM and SM 
visits.  In Alabama, Arkansas, and North Carolina the difference between these two pairs 
of visit types is at least 10 miles, and no state has less than a 5-mile difference in assigned 
distance to MDM and SM appointments.  This indicates that the distance travelled by the 
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Medicaid population to receive specialist care is significantly higher than the distance to 
receive any other type of care.  For the Medicaid population, having to travel an additional 
10 miles to receive specialist care may be a greater barrier to receive care than the same 
distance would be for a patient in the non-Medicaid population due to other financial and 
transportation restrictions. 
Tukey’s test shows that there is not a statistically significant difference in the average 
unmet need between any pair of states for rural MD or MDM visits, and the difference 
between S and SM unmet need is only significant for 3 and 4 pairs of states respectively.  
This means that the need for improvement in the availability of providers is, at a state level, 
similar for rural areas in all states.  In urban areas, on the other hand, there are significant 
differences for every pair of states in the unmet need for at least one provider type, with 
the exception of Tennessee and Mississippi who have no significant differences in unmet 
need. 
Georgia has the lowest percent of unmet need for non-Medicaid visits out of all of 
the states, with less than 1% of the need being unmet in both urban and rural areas.  For 
the Medicaid population, Mississippi has the lowest percent of unmet need in both rural 
and urban areas, with Georgia and Tennessee having similarly low values in urban areas 
(within only 0.2% of the unmet need observed in Mississippi).   
The percent of unmet need for non-Medicaid visits is greater in rural areas than urban 
areas in all seven states.  For Medicaid visits, the percent of unmet need is greater in rural 
areas than urban areas for five states, while Arkansas and Mississippi have greater unmet 
need in urban areas.  The difference in unmet need between the urban and rural Medicaid 
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populations in Arkansas is the greatest difference between geographic areas in any state, 
with 5.2% of the need being unmet in rural areas and 10.3% being unmet in urban areas.  
This indicates a shortage of Medicaid-accepting providers even in the larger cities in 
Arkansas.   
This shortage of Medicaid accepting providers in Arkansas’ urban areas is 
highlighted again when comparing the percent of unmet need in urban areas between the 
Medicaid and the non-Medicaid populations.  In Arkansas, this difference is the largest 
across all of the states, with over 8% more need being unmet for the urban Medicaid 
population than the urban non-Medicaid population and the next largest difference is only 
6%, which is observed in Alabama.  Mississippi has the smallest difference, with only 1% 
more unmet need for Medicaid than non-Medicaid visits in urban areas. 
For children in rural areas, the percent of unmet need is greater in the Medicaid 
population than the non-Medicaid population for every state except Mississippi, where the 
unmet need for non-Medicaid visits is 0.1% higher than the unmet need for Medicaid visits.  
The largest difference is in Tennessee, where only 1.7% of the need for non-Medicaid visits 
is unmet in rural areas, but 10.3% of the Medicaid need is unmet.  Because the unmet need 
for non-Medicaid visits is so low in Tennessee, increasing the percent of providers that 
accept Medicaid in some rural areas may be sufficient to improve access to Medicaid 
specialist care without needing to increase the absolute number of providers.  Further 
analysis on the provider capacity would be necessary to determine if allocating any excess 
capacity for non-Medicaid visits to Medicaid visits would be sufficient to significantly 
reduce the unmet need for rural Medicaid visits.  In addition, potential incentives to 
providers to accept Medicaid patients should be evaluated. 
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While the unmet need is similar across the seasons in terms of the percent of visits 
that are unassigned, the absolute number of visits that are unmet is worth addressing.  The 
number of visits needed in the fall is higher than in the spring or summer, so if the same 
percent of need in each season is unmet, there will be more unmet need in terms of visits 
in the fall.  For example, in Alabama the percent of unmet need is the same in all three 
seasons, but there are 1100 more visits that cannot be assigned in the fall than in spring or 
summer. This means that there are roughly 1100 more children who are not receiving the 
necessary asthma care in the fall.  Inadequate care is known to result in worse asthma 
outcomes, and in some cases these outcomes may be severe or require more expensive care 
[103].   
The interventions that might be implemented in across communities and states may 
differ; not all will have the same potential impact on the number of children served.  Any 
intervention should be evaluated in terms of the additional number of children served as 
well as the geographic coverage of the children served because an urban intervention may 
impact a large number of children in a small geographic space while a rural intervention 
may impact all of the children in multiple census tracts that previously had no access to 
care.   
Limitations 
Important limitations of this study are related to the data.  There are many providers 
in the Medicaid database that record asthma visit claims but are not classified as primary 
or asthma care providers, and it is not possible to determine why these claims are recorded 
or the exact type of service provided.  In addition, we are estimating the demand for asthma 
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visits using tract level population and state level prevalence values that are broken down 
by gender.  It would be advantageous to be have more granular prevalence estimates that 
combined multiple demographic factors, such as prevalence by both age and race together, 
rather than one or the other.  While assuming that all of the population in a census tract is 
located at the centroid for the optimization model is computationally efficient, this 
aggregation may be problematic in 5-10% of census tracts[28].  This assumption means 
that the individual driving distance for patients within a tract may vary from the estimate 
by a few miles, the significance of which depends on many additional factors that are 
individual to each child.  A key assumption that we make is that the capacity for asthma 
visits is the same for Medicaid and non-Medicaid children at each provider location.  
Comparisons with other data sources that include the non-Medicaid population would be 
needed to determine for which states or provider types this assumption should be adjusted.   
Other limitations are related to the model assumptions. We assume that the time to 
receive an appointment is not a significant factor so long as there is capacity within the 
given season, which is a multiple month time period.  It is possible that some children may 
not be able to receive an appointment within the needed time frame even though there is 
capacity in the season as a whole.  In addition, everything in the model is computed in 
terms of driving distance, including the penalty for receiving primary instead of specialist 
care.  For children with the most severe asthma cases, this uniform distance penalty may 
not be an accurate representation of their preference.  
In spite of these limitations, this study provides details about the availability of 
asthma care and the capacity of providers that is allocated to pediatric asthma visits, and it 
identifies areas of improvement for access to asthma car in each state.  
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CHAPTER 4. HEALTHCARE UTILIZATION AMONG 
MEDICAID-ENROLLED ADOLESCENTS DIAGNOSED WITH 
DEPRESSION 
4.1 Introduction 
According to the National Institute of Mental Health, depression currently affects 
between 7-15% of adolescents ages 12 to 17 in the United States[104, 105]. Conservative  
estimates of the underlying epidemiological prevalence of depression for adolescents give 
a lower bound of 4% to 8%[106, 107] while 18% of adolescents in one study showed 
symptoms of depression[108].  Other studies find that major depressive disorder, which is 
just one sub-category included in depression diagnoses, affect 7.5% of adolescents and that 
10.7% have at least one major depressive episode each year[109, 110] Depression has a 
significant impact on the lives of affected youth, and can compound the effects and costs 
of other conditions acquired over the course of their lifetime. For example, major 
depression among youth can cause a two-point increase in average adult BMI[111], and 
teenage depression increases the risk of becoming obese later in life [112, 113]. Depression 
has been found to be undertreated, with prevalence rates varying with gender, race, age, 
and income[105, 108]. If left untreated, depression can cause lifelong health complications 
and increased healthcare costs, especially if other mental and physical health comorbidities 
are present[114, 115].  
To assess the prevalence of diagnosis and/or treatment of depression and other 
conditions, the Centers for Disease Prevention and Control (CDC) has published survey 
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results for the general child and adolescent population derived from self-reported 
surveys[107]. The estimates derived from these surveys, however, are not available for 
pediatric subpopulations such as Medicaid-insured children, a vulnerable population facing 
many access barriers to care including the low rates of acceptance of public insurance 
among healthcare providers, and lack of education about depression and the importance of 
evidence-based treatment[116-118]. Moreover, Medicaid is the largest insurance program 
for children in the U.S., with more than 27 million children enrolled nationally. 
Understanding healthcare utilization for treating depression in the Medicaid-enrolled 
adolescent population is important in assessing whether state Medicaid programs provide 
appropriate behavioral and mental healthcare, with comparisons across states[119, 120].  
Some studies in the literature have provided an analysis for a limited time frame, 
geographic region (often a single state) or set of treatment options[108, 121-123].   
This study provides the largest and most comprehensive analysis of the receipt of 
treatment for depression among Medicaid-enrolled youth.  Specifically, this study provides 
critical information about the treated prevalence of depression 12 states, as well as the types 
of services received for depression.  The 12 states vary in the management mental and 
behavioral health of the Medicaid enrollees, including managed care (Georgia, Louisiana, 
Minnesota, South Carolina, Tennessee, Texas), fee for service (Alabama, Arkansas, New 
York), carve-out (Florida), and local management (North Carolina) [124]. The findings 
from this study provide much needed baseline information about treatment for depression 




4.2.1 Data Source 
The primary data source is the Medicaid Analytic eXtract (MAX) files, consisting 
of identifiable individual-level claims data with information on service utilization and 
expenditures for all Medicaid-enrolled beneficiaries.  The states in this study are Alabama 
(AL), Arkansas (AR), Florida (FL), Georgia (GA), Louisiana (LA), Mississippi (MS), 
Minnesota (MN), North Carolina (NC), New York (NY), South Carolina (SC), Tennessee 
(TN), and Texas (TX).  
We obtained the Institutional Review Board (IRB) approval from Georgia Tech 
University for this study.   
Extremely low prevalence and utilization rates in CA and PA led us to investigate 
the health care reporting policies in those states.  They elected to exclude or “carve-out” 
mental and behavioral health services from managed care programs[124], and thus data on 
such services are not completely reported to the state Medicaid program. For this reason, 
these two states have been removed from the analysis. 
The study population consists of all Medicaid-enrolled adolescents age 12 to 17, 
with claims having a primary or secondary diagnosis code pertaining to depression. This 
includes  major depression, dysthymia, and depression not otherwise specified (identified 
using International Classification of Diseases Code ninth revision (ICD-9) codes 296.2X, 
296.3X, 300.4, and 311[125]).  Although depression can be diagnosed at any age and 
medication recommendations begin at the age of 6, the healthcare community widely uses 
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age 12 as the lower bound for research on pediatric depression because of the significant 
increase in the rates of depression at that age[104, 126, 127].  We included adolescents in 
the study population if they had at least two recorded healthcare visits with a depression 
diagnosis at different time points over the entire time period in order to exclude patients 
with a misdiagnosis or single improperly coded visit.  
We extracted claims data from the Other Services Record (OT) and the Drug 
Record (RX) MAX files to determine per-patient and overall service utilization summaries 
for the study sample. Included for each claim from the OT files were data entries specifying 
the date of service, the patient identification number, the ICD-9 code, the procedure code, 
and the type and place of service codes.  
We extracted a comprehensive list of approved drugs for treating major depression, 
excluding bipolar depression, from the National Committee for Quality Assurance 
(NCQA)[128].  
4.2.2 Treated Prevalence Estimation 
Using claims data, we capture treated prevalence defined as the proportion of children 
diagnosed and treated for depression. We estimated treated prevalence of depression in 
each state by dividing the total number of Medicaid eligible months for each child in the 
study population by the total number of Medicaid eligible months of all adolescents in the 
study population for the corresponding state and year.   
We extracted the following variables from the MAX other therapy table: patient_id, 
STATE_CD, MAX_YR_DT, EL_DOB, EL_SEX_CD, EL_RACE _ETHNCY_CD, 
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MSIS_TOS, PLC_OF_SRVC_CD, PRCDR_CD, SRVC_BGN_DT, NPI, DIAG_CD_1, 
and DIAG_CD_2. We extracted the EL_ELGBLTY_MO_CNT and 
EL_RSDNC_CNTY_CD_LTST variables from the MAX personal summary table.  
The patient_id was used to keep track of each patient throughout the study. We used 
the STATE_CD to group the overall population into subpopulations by state. The 
MAX_YR_DT and EL_DOB were used to calculate the age of the patient when the claim 
was submitted. The EL_SEX _CD and RACE_ETHNCY _CD were used to classify each 
claim by strata (either male or female and either white, black, or other). The PRCDR_CD, 
PLC_OF_SRVC_CD, and MSIS_TOS were used to determine the type of claim (either 
behavioral therapy, emergency room, or other depression). DIAG_CD_1 and DIAG_CD_2 
were used to determine if the claim was depression related. The EL_ELGBLTY 
_MO_CNT was used to calculate the total number of eligible months for all patients in the 
population in order to calculate per member per year statistics. The 
EL_RSDNC_CNTY_CD_LTST was used to determine the urbanity of the patient using 
the rural-urban continuum codes (RUCC). 
We extracted the following variables from the MAX prescription drug table: patient_id, 
STATE_CD, MAX_YR_DT, and NDC. We only extracted RX claims for patients from 
the population from the OT table. The STATE_CD and MAX_YR_DT were used to 
categorize each RX claim by state and year, and the NDC was used to determine if the drug 
was used to treat depression.  
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Our final step was to aggregate the claims into visits. Multiple non-prescription claims 
in a single day (determined by SRVC_BGN_DT) for the same patient (determined by 
patient_id) and same provider (determined by NPI) were considered as a single visit. 
Table 19:Selected MAX files data elements to identify the depression baseline 
Variable Description 
DIAG_CD_1 The First ICD-9-CM Diagnosis Code for the Record 
DIAG_CD_2 The Second ICD-9-CM Diagnosis Code for the Record 
EL_DOB Birth Date of the Medicaid Eligible 
EL_ELGBLTY_
MO_CNT 
Total Number of Months the Individual Was Eligible for Medicaid 
During the Calendar Year 
EL_RACE 
_ETHNCY_CD 
Race/Ethnicity of The Medicaid Eligible 
EL_RSDNC_CN
TY_CD_LTST 
Federal Information Processing Standard (FIPS) Code Indicating 
the Eligible's County of Residence 
EL_SEX_CD Code Indicating the Gender of the Medicaid Eligible 
MAX_YR_DT Calendar Year Covered by the Max Personal Summary File 
MSIS_TOS 
Code Indicating the Medicaid Statistical Information System 
(MSIS) Type of Service 
NDC National Drug Code (NDC) for the Service 
NPI 
National Provider Identifier of the Provider Who Treated the 
Recipient (As Opposed to the Provider Billing for the Service) 
patient_id 
Unique Identification Number Used to Identify a Medicaid 




Code Indicating the Place Where the Service Was Performed 
PRCDR_CD Procedure (Service) Provided 
SRVC_BGN_DT The Beginning Date of Service for the Claim 
STATE_CD 
U. S. Postal Service 2-Character Abbreviation for the State 
Medicaid Agency Submitting the Data 
4.2.3 Outcome Measures 
We considered multiple claims for the same type of care in a single day as one 
healthcare utilization event or visit. We classified each of the events with a depression 
diagnosis as psychotherapy and other psychosocial services (PS), medication (re)filled 
(RX) scaled to a 30-day supply, or emergency department visit (ED). We determined if a 
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given care event was a PS event based on the place and type of service for the visit as well 
as whether or not the procedure code was a PS code. We classified an event as an ED event 
based on the place of service code.  
We derived two utilization outcome measures for each service: 
1. Treatment exposure rate estimated as the percentage of youth in the study 
population who have had at least one psychological service, medication (re)fill, or 
ED visit. 
2. Utilization rate estimated as the per-patient per-year (PPPY) rates for each service, 
specifically, aggregated counts for the service divided by the total enrollment 
months for all the adolescents diagnosed with depression who received the service 
and multiplied by 12. 
We stratified our key outcome variables by several child characteristics including:  age, 
race, gender, the residential urbanicity level given by the Rural-Urban Continuum Codes, 
Medicaid eligibility criteria, and clinical risk grouping (CRG) derived using the 3M 
Clinical Risk Grouping software.   
We categorized the age variable as 12 -14 or 15-17. We considered three categories for 
the race category: white, black, and other (American Indian, Asian, Hispanic with no race 
information given, Hispanic and one or more races, Pacific Islander, More than One, 
Other). Each patient’s county code was identified from the personal summary table, and 
we used the rural-urban continuum codes (RUCCs – shown in Table 20 below)[129] to 
determine whether that county was urban (1,2,3), suburban (4,5,6), or rural (7,8,9).  
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Counties are assigned an RUCC by the Economic Research Service division at the U.S. 
Department of Agriculture.  Medicaid eligibility is grouped into disabled, foster, or other.   
Table 20: Rural Urban Continuum Code (RUCC) definitions 
Code Description 
Metro counties: 
1 Counties in metro areas of 1 million population or more 
2 Counties in metro areas of 250,000 to 1 million population 
3 Counties in metro areas of fewer than 250,000 population 
Non-metro counties: 
4 Urban population of 20,000 or more, adjacent to a metro area 
5 Urban population of 20,000 or more, not adjacent to a metro area 
6 Urban population of 2,500 to 19,999, adjacent to a metro area 
7 Urban population of 2,500 to 19,999, not adjacent to a metro area 
8 Completely rural or less than 2,500 urban population, adjacent to a metro area 
9 
Completely rural or less than 2,500 urban population, not adjacent to a metro 
area 
To assess the total severity of each person, we derived the CRGs using the 3M™ Core 
Grouping Software version 2014.3.2 with the Clinical Risk Groups version 1.12. While the 
CRGs by 3M have multiple levels of granularity (summarized in Table 21 below with 
additional details in Appendix B), we grouped patient CRGs as either low-risk (CRG 1 to 
CRG 5a) or medium-to-high-risk (CRG 5b to CRG 9). We grouped the medium and high 
risk CRGs together because there were few high-risk patients (patients with a clinical risk 
group of 8 or 9) within the study population.  
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Table 21: Clinical Risk Group (CRG) category definitions 
CRG Description 
1 Healthy 
2 Recent History of Significant Acute Disease 
3 Single Minor Chronic Disease 
4 Minor Chronic Disease in Multiple Organ Systems 
5a Single Moderate Chronic Disease 
5b Single Dominant Chronic Disease 
6 Significant Chronic Disease in Multiple Organ Systems 
7 
Dominant Chronic Disease in Three or More Organ 
Systems 
8 Dominant, Metastic, and Complicated Malignancies 
9 Catastrophic Conditions 
4.2.4 Statistical Analysis 
To compare utilization across states, the 2012 county level PPPY for each state and 
treatment type were used.  For each of the three visit types, Analysis of Variance (ANOVA) 
was used to test the null hypothesis that the average utilization in all 12 states is the same.  
Pairwise comparison was then applied for the analysis of each pair of states.   
4.3 Results 
4.3.1 Study Population 
The total population for each state consisted of the number of unique adolescents across 
the eight years of the study. A summary of the population over the entire horizon of 2005 







Table 22: Depression Patients by Demographics from 2005 to 2012 
  State AL AR FL GA LA MN MS NC NY SC TN TX 
Age 
12 to 14 35 37 38 39 36 34 37 37 38 34 32 40 
15 to 17 65 63 62 61 64 66 63 63 62 66 68 60 
Race 
White 59 66 40 50 55 64 45 51 35 57 74 28 
Black 36 22 24 41 40 14 46 38 20 34 19 15 
Other 5 13 36 9 6 22 9 11 45 9 7 57 
Gender 
M 39 42 41 43 41 42 42 42 39 39 41 43 
F 61 58 59 57 59 58 58 58 61 61 59 57 
Long/Short 
Term 
LT 46 56 36 42 44 55 49 49 45 46 47 44 
ST 54 44 64 58 56 45 51 51 55 54 53 56 
Urbanicity 
Urban 69 57 93 77 79 68 38 73 90 81 69 85 
Suburban 25 24 7 16 18 20 36 22 9 18 24 12 
Rural 5 19 0 6 3 12 24 5 1 1 7 3 
Eligibility 
Other 75 82 66 67 80 82 75 77 76 79 77 66 
Foster 7 6 16 21 7 8 6 10 8 12 14 20 




8 6 16 8 9 14 4 7 14 14 10 8 
High 
Risk 
93 94 85 93 91 86 96 93 87 86 90 92 
Table 23 includes the percent of adolescents from the study population that have 
depression in each stratum subcategory by state for 2012. The size of the study population 
ranges from 14,846 children with depression in MS (3,058 in 2012) to 87,757 children in 
TX (19,639 in 2012). 
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Table 23:2012 Sample Characteristics Among Medicaid-Enrolled Youth with Depression Diagnosis Across 12 States  
Sample Characteristics AL AR FL GA LA MN MS NC NY SC TN TX 
Population             
Number of Children with Depression 3901 5974 9753 8294 6918 8865 3058 8386 16048 4040 6940 19639 
Treated Prevalence 2.84% 4.9% 2.0% 3.3% 3.3% 8.3% 3.2% 3.5% 3.2% 2.7% 3.7% 2.8% 
Age Group             
12 to 14 46% 48% 45% 50% 47% 48% 49% 49% 45% 43% 45% 50% 
15 to 17 54% 52% 55% 50% 53% 52% 51% 51% 55% 57% 55% 50% 
Race/Ethnicity             
White 59% 64% 39% 49% 53% 63% 47% 50% 38% 57% 73% 25% 
Black 35% 19% 22% 39% 41% 13% 45% 36% 19% 32% 18% 13% 
Other 6% 17% 39% 12% 5% 24% 8% 14% 44% 11% 8% 62% 
Urban/Rural Setting             
Rural 5% 18% 0% 5% 3% 12% 21% 3% 1% 1% 7 3% 
Suburban 26% 22% 6% 16% 17% 19% 34% 20% 10% 16% 23% 11% 
Urban 
68% 61% 94% 79% 80% 69% 43% 77% 89% 83% 70% 86% 
Clinical Risk Grouping (CRG)             
Low 7% 6% 13% 5% 12% 11% 5% 5% 11% 13% 8% 6% 
Medium/high risk 93% 94% 87% 95% 88% 89% 95% 95% 89% 87% 92% 94% 
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In all 12 states, there were more depression-diagnosed adolescents aging from 15 
to 17 than depression-diagnosed adolescents aging from 12 to 14, more females than males, 
more from urban areas than from suburban or rural areas, more from the “other” eligibility 
class than disabled or foster children, and more in medium-to-high risk CRGs than in low-
risk CRGs. There were more depression-diagnosed white children than of any other race 
in all states except MS, NY, and TX.  
Between 20% (in SC) and 52% (in LA) of the depression related claims extracted 
in each state had either a primary or secondary diagnosis code for major depression (codes 
296.2X and 296.3X).  The complete breakdown of the percent of visits by state for each 
ICD9 code is provided in Table 24 below. 














AL 318,705 18.9% 19.1% 8.6% 54.2% 37.9% 
AR 1,416,605 11.1% 17.8% 10.7% 60.9% 28.8% 
FL 977,245 14.4% 19.0% 21.4% 45.4% 33.3% 
GA 725,724 18.8% 27.7% 12.8% 41.0% 46.4% 
LA 608,369 22.4% 29.7% 3.1% 45.0% 52.0% 
MN 1,094,646 16.7% 21.8% 18.9% 43.7% 38.4% 
MS 397,655 15.3% 14.1% 8.3% 62.5% 29.3% 
NC 2,170,799 20.0% 25.1% 14.5% 41.0% 44.0% 
NY 1,365,456 12.8% 16.4% 19.4% 51.5% 29.2% 
SC 465,889 11.1% 9.1% 7.6% 72.3% 20.1% 
TN 541,402 14.6% 20.3% 7.2% 58.2% 34.8% 
TX 1,447,385 25.8% 25.3% 9.5% 39.6% 51.1% 
4.3.2 Treated Prevalence Estimation 
Figure 19 shows the treated prevalence of depression for each state and year in the 
study, with corresponding data values in Table 25.  The percentages were calculated by 
dividing the total number of Medicaid eligible months for each depression population in 
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each state and year by the total number of Medicaid eligible months of the total number of 
Medicaid patients aging from 12 to 17 for the corresponding state and year. The total 
population for each state consists of the number of unique patients across the eight years 
of the study.  
 
Figure 19: Treated Prevalence of Depression among Medicaid-Enrolled Youth (age 
12-17), by state from 2005-2012 
Table 25: Depression Prevalence by State and Year 
State Total 
Population 
2005 2006 2007 2008 2009 2010 2011 2012 
AL 12,245 2.67% 2.90% 3.00% 2.92% 3.05% 3.02% 2.87% 2.84% 
AR 20,550 5.50% 5.97% 5.88% 5.72% 5.36% 5.26% 4.81% 4.90% 
FL 25,829 2.48% 1.92% 1.16% 1.35% 1.95% 1.72% 1.68% 2.02% 
GA 26,994 3.56% 3.46% 3.33% 3.74% 3.72% 3.70% 3.18% 3.28% 
LA 18,553 2.35% 2.38% 2.60% 2.49% 2.72% 2.87% 3.18% 3.32% 
MN 21,048 7.08% 7.37% 7.44% 7.11% 7.43% 7.81% 7.88% 8.25% 
MS 13,218 2.97% 3.41% 3.70% 3.56% 3.51% 3.43% 3.24% 3.15% 
NC 37,518 4.44% 4.73% 5.09% 5.32% 5.13% 4.76% 4.40% 3.48% 
NY 41,875 2.27% 2.32% 2.36% 2.48% 2.55% 2.58% 2.97% 3.17% 
SC 9,815 3.20% 3.25% 3.22% 2.94% 2.78% 2.79% 2.85% 2.72% 
TN 25,482 3.88% 3.72% 3.38% 3.17% 3.14% 3.21% 3.47% 3.67% 
TX 73,957 3.38% 3.39% 3.36% 3.29% 3.19% 3.12% 2.95% 2.84% 
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From 2005 to 2012, half of the states have an overall increase in treated prevalence 
of pediatric depression, while half have an overall decrease.  The change in the treated 
prevalence is no more than 1.2% in either direction. MN had the highest overall treated 
prevalence of depression across all years and the largest increase over time, reaching 8.3% 
in 2012.  FL has the lowest treated prevalence from 2006-2012, reaching just 2%. 
4.3.3 Population Outcome Measures 
Treatment exposure rates and utilization rates (PPPY utilization) in 2012 for each 
treatment type are shown in Table 26.   
Table 26: 2012 Depression Service Utilization (as percent and Per Patient Per Year -




AL AR FL GA LA MN MS NC NY SC TN TX 
Total Number of 
Depression 
Visits (PPPY) 









4.8 12.8 4.3 8.1 0.6 4.6 8.9 0.6 1.8 3.8 3.8 2.1 
Any Medication 
Prescription (%) 
62% 59% 47% 53% 67% 61% 58% 52% 38% 61% 53% 60% 
# Medications 
Filled (PPPY) 
4.18 3.73 2.71 3.68 3.67 4.77 3.11 3.40 2.26 3.64 3.29 4.05 
Any ED Visit 
(%) 
33% 43% 34% 22% 32% 35% 29% 20% 71% 14% 17% 26% 
# ED Visits 
(PPPY) 
1.75 1.56 1.70 0.93 1.17 1.85 2.38 0.98 5.96 0.28 0.39 1.18 
The treatment exposure rate for PS ranges from 9% in NC and 13% in LA to 61% 
in GA and 66% in AR.  For ED visits, SC and TN have the lowest treatment exposure rates 
with only 14% and 17% respectively, and NY has the highest with 71% of children with 
depression going to the ED at least once in 2012.  There is the least variation across the 
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states for RX treatment exposure, ranging from 38% in NY to 67% in LA.  
 
Figure 20 shows the PS utilization rates across eight years for 12 of the states in the 
study, AR had the highest, while LA and NC had the lowest average PS utilization rate 
across all years of the study with 12.78 and less than 1 visits PPPY respectively.  FL had 
the largest decrease in PS utilization rate over time, dropping from 9.96 visits PPPY in 
2005 to 4.29 visits PPPY in 2012.  AL, SC and TX each decrease by at least one visit 
PPPY.  GA has the largest increase over time, rising from 2.63 PS events PPPY in 2005 to 
9.13 PS events PPPY in 2012. AR, MN, MS and TN also increase by at least 2 visits PPPY.  
The remaining states, LA, NC, and NY have little change in utilization rates over time.  
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Figure 20: Psychological Service Utilization (Assessed by Number of PS Visits Per 
Patient Per Year), by State from 2005 to 2012.  Note: PPPY is calculated as the 
aggregated count for PS events divided by the total number of enrollment months 
for all the adolescents with those services multiplied by 12. 
Figure 21 shows the PPPY utilization of ED services from 2005-2012.  The 
majority of the states had steady ED utilization rates over time, changing by less than 0.5 
visits PPPY.  FL and MN had overall increasing trends in ED utilization, while AL, NC, 
and NY had decreasing utilization by over 2.5 visits PPPY over the time horizon.  
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Figure 21: Emergency Department Utilization (Assessed by Number of ED Visits 
Per Patient Per Year), by State from 2005 to 2012.  Note: PPPY is calculated as the 
aggregated count for ED events divided by the total number of enrollment months 
for all the adolescents with those services multiplied by 12. 
Figure 22 shows the distribution of RX utilization rates across eight years for all of 
the states in the study, except for MN in 2010 and LA in 2011 which are not available 
because of data incompleteness. All of the states have an overall increase in RX utilization 
rates over time. The weighted average utilization rate of RX across all states and years is 
3.08 RX fills PPPY. MN has the highest average RX utilization rate across all years of the 
study with 3.97 fills PPPY, and NY has the lowest average RX utilization rated across all 
years of the study with 1.89 fills PPPY.  In 2012 MN has highest RX utilization rate, with 
4.77 depression-related RX fills per patient, followed closely by AL and TX that also have 
over 4 RX fills PPPY.  The average increase in RX utilization rates from the first year to 
the last year of the study across all of the states is 1.22 RX fills PPPY, with a high of a 1.87 
increase for MN and a low of a 0.7 increase in AL.  
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Figure 22: Medication Utilization (Assessed by Number of Visits Per Patient Per 
Year), By State from 2005 to 2012.  Note: PPPY is calculated as the aggregated 
count for RX events divided by the total number of enrollment months for all the 
adolescents with those services multiplied by 12. 
Table 27 contains the number of per patient per year (PPPY) visits for three 
different depression events (psychological service, emergency department, or medication 








Table 27: PPPY Visits by State, Event, and Year 
State 
Event 
Type 2005 2006 2007 2008 2009 2010 2011 2012 
AL ED 4.38 3.92 3.45 1.88 2.00 1.56 1.63 1.75 
AR ED 1.72 2.21 2.15 2.18 2.04 1.84 1.87 1.56 
FL ED 1.02 0.98 1.03 1.50 1.53 1.61 1.49 1.70 
GA ED 1.02 0.72 0.76 0.91 0.86 0.92 0.94 0.93 
LA ED 1.64 1.69 1.56 1.39 1.46 1.35 1.40 1.17 
MN ED 0.82 0.87 1.06 1.07 1.62 1.66 1.62 1.85 
MS ED 2.33 2.09 2.23 1.92 2.46 2.52 2.33 2.38 
NC ED 6.16 2.56 1.65 1.06 1.29 1.67 1.36 0.98 
NY ED 8.62 8.12 7.35 7.00 7.10 7.10 6.77 5.96 
SC ED 0.61 0.64 0.62 0.71 0.64 0.70 0.53 0.28 
TN ED 0.57 0.34 0.31 0.43 0.45 0.44 0.44 0.39 
TX ED 1.43 1.37 1.36 1.17 1.37 1.50 1.38 1.18 
AL PS 6.26 5.10 4.74 3.36 3.43 3.66 4.55 4.77 
AR PS 9.52 9.28 9.56 9.81 12.49 13.10 13.18 12.78 
FL PS 9.96 8.02 3.65 3.19 3.53 2.99 2.48 4.29 
GA PS 2.63 3.86 6.31 6.60 6.96 7.17 7.58 8.13 
LA PS 0.63 0.59 0.65 0.69 0.79 0.84 0.72 0.56 
MN PS 2.35 2.66 2.97 2.98 3.67 4.25 4.30 4.61 
MS PS 5.34 5.66 6.69 6.64 6.18 5.71 5.99 8.09 
NC PS 0.60 0.57 0.44 0.43 0.50 0.51 0.51 0.57 
NY PS 0.63 0.66 0.71 0.82 1.11 1.21 1.53 1.84 
SC PS 4.49 4.37 4.20 3.95 4.01 3.52 3.77 3.81 
TN PS 1.21 1.76 2.21 1.95 1.83 1.71 2.13 3.81 
TX PS 3.76 3.38 2.98 2.89 2.79 2.69 2.66 2.08 
AL RX 3.48 3.47 3.54 3.49 3.81 4.04 4.07 4.18 
AR RX 2.66 3.11 2.91 2.94 3.30 3.42 3.62 3.73 
FL RX 1.59 2.12 2.38 1.95 2.39 2.65 2.83 2.71 
GA RX 2.37 3.01 2.23 2.76 3.28 3.43 3.72 3.68 
LA RX 2.54 3.43 3.49 3.60 3.60 3.79 7.61 3.67 
MN RX 2.90 3.70 3.64 3.89 4.46 8.98 4.66 4.77 
MS RX 1.71 2.00 2.17 2.31 2.67 3.10 2.98 3.11 
NC RX 2.29 2.70 2.46 2.42 2.73 2.94 3.25 3.40 
NY RX 1.35 1.81 1.76 1.74 1.96 2.07 2.12 2.26 
SC RX 2.18 2.57 2.46 2.40 2.19 2.06 2.41 3.64 
TN RX 2.00 2.41 2.49 2.72 2.96 3.13 3.28 3.29 
TX RX 2.79 3.58 3.49 3.26 3.70 3.90 4.05 4.05 
4.3.4 Stratified Outcome Measures 
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The number of depression-related events PPPY varied across the states, but there 
were some clear utilization patterns within the strata.  Utilization rate is higher for female 
and medium/high clinical risk children than for male and low clinical risk children in 10 
states.  In 2/3 of the states, older children and children in foster care have higher utilizations 
than the other sub-groups, and in a majority of the states, children living in urban areas 
have the most visits PPPY.  The greatest variation between the states is in the utilization 
patterns by race, with black children having the highest utilization in 2 states while white 
and other race children have the highest utilization rates in 5 states each.   
While children in foster care have the highest PPPY utilization in 9 states, the 
largest percent of total visits in every state is made by children with an income-based 
eligibility criterion (neither disabled or in foster care).  Similarly, the largest percent of 
visits in all states are made by children living in urban areas, even though in 5 states they 
do not have the highest utilization rates.  In every state medium/high clinical risk children 
are responsible for at least 90% of the total visits, and in all states except MS and TX white 
children receive the most visits.  
Table 28 provides the percentage of depression-related visits per patient per year 
utilized by each stratum subcategory for each state in 2012. An example of how to read  
Table 28 is as follows: for Alabama in 2012, 45% of depression related visits were 
attended by patients aging from 12 to 14, 59% of depression related visits were attended 
by white patients, and 12% of depression related visits were attended by foster children.
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AL 45% 55% 36% 6% 59% 37% 63% 68% 32% 4% 24% 72% 20% 12% 68% 4% 96% 
AR 49% 51% 21% 20% 59% 43% 57% 81% 19% 17% 21% 62% 19% 8% 73% 4% 96% 
FL 44% 56% 21% 41% 38% 36% 64% 62% 38% 0% 4% 96% 19% 18% 63% 11% 89% 
GA 46% 54% 42% 15% 43% 39% 61% 72% 28% 4% 13% 83% 22% 36% 42% 3% 97% 
LA 47% 53% 34% 6% 60% 37% 63% 63% 37% 2% 16% 82% 15% 8% 77% 8% 92% 
MN 46% 54% 11% 22% 67% 37% 63% 77% 23% 10% 20% 70% 10% 8% 82% 9% 91% 
MS 51% 49% 53% 9% 38% 38% 62% 74% 26% 22% 33% 43% 21% 9% 71% 4% 96% 
NC 47% 53% 27% 11% 61% 36% 64% 67% 33% 2% 21% 76% 14% 14% 73% 4% 96% 
NY 45% 55% 17% 43% 39% 35% 65% 74% 26% 1% 9% 90% 18% 6% 76% 9% 91% 
SC 44% 56% 29% 14% 57% 37% 63% 75% 25% 1% 13% 86% 12% 10% 78% 11% 89% 
TN 41% 59% 18% 8% 74% 40% 60% 70% 30% 6% 24% 70% 8% 21% 71% 8% 92% 
TX 52% 48% 12% 60% 29% 39% 61% 62% 38% 3% 11% 86% 18% 26% 55% 5% 95% 
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Bar charts with the stratified percent of visits made by children in each category 
can be found in Appendix C.1.   
4.3.5 State Level Utilization Differences 
For all three visit types, we reject the null hypothesis that the mean utilization in all 
states is the same (p-value <2e-16).  Five pairs of states do not have significantly different 
means for PS, ED, or RX, and 12 pairs of states have different means for all three visit 
types.  MS has the least in common with the other states.  It has significantly different 
utilization rates for all three service types in 6 of its 11 pairwise comparisons and 
statistically different utilization for 2 of the 3 service types in the other 5 comparisons.   
4.4 Discussion 
Using Medicaid data from multiple states, this study derives the largest, most 
comprehensive sample to describe the overall treated prevalence for depression and the 
levels of mental and behavioral health services received by those with a diagnosis of 
depression.  We find that: (1) the overall treated prevalence of depression is very low in 
this population; (2) the overall receipt of psychological services for depression is also very 
low (given that this is often the first-line treatment for depression according to 
recommended care guidelines[130]; (3) there is statistically significant variation in receipt 
of services across states; and (4) there are important trends over time across all states.   
This study shows that the overall treated prevalence of depression is lower than 
expected in the Medicaid population. The treated prevalence across the states studied 
ranges from 2% to 8.3% in 2012.  Only AR and MN had treated prevalence in each year 
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close to reported depression prevalence (4-8% from self-reported surveys[107], 7.5% with 
major depressive disorder[109], or 10.7% with at least one major depressive episode each 
year[110]). The treated prevalence in NC drops below 4% in 2012, and all of the other 
states have treated prevalence that is below 4% for the entire study period. This is 
particularly noteworthy considering the fact that these are low-income youth with even 
greater risk factors for depression[131].  Thus, the data suggest that under-diagnosis of 
depression is of concern for Medicaid-enrolled youth.  The fact that the vast majority of 
the sample were in the medium to high risk CRG category provides some evidence to 
suggest that those who are actually being treated for depression have multiple/complex 
chronic conditions.  Therefore, it is possible that other co-morbid mental health or physical 
health problems that are the motivating factor that brings them into services, rather than 
just having depression in and of itself.   
The overall use of psychological services for depression is also highly variable and 
in many states, very low.  The percentage of children with depression that received any 
psychological service in a particular state is between 9% in NC and 66% in AR.  PPPY 
visits have a similar span, ranging from 0.56 visits PPPY in LA to over 12 visits PPPY in 
AR. However, the gap from between PPPY utilization in AR and the next highest state 
(8.13 PPPY in GA) is much larger than the gap in the percent of children receiving any 
psychological service, which is 61% in GA.  This finding is especially concerning because 
psychotherapy services are supposed to be the first-line treatment for youth with depression 
per the AACAP clinical guidelines. Medication is only supposed to be used for those whose 
depression does not improve after receiving these services in part because of the potentially 
severe side effects[127, 130, 132].  Furthermore, the average number of psychological 
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services visits is especially low.  Although there is no specific cutoff for how many 
psychotherapy visits should be received for youth with depression, prior studies have used 
thresholds of 4 visits and 8 visits to characterize whether someone received minimally 
adequate psychotherapy[133, 134].  Thus, with 6 states having fewer than 4 and 9 states 
having fewer than 8 visits PPPY, our findings suggest that most of those who do receive 
PS may not receive enough visits to receive minimally adequate treatment with 
psychotherapy and other psychosocial services.  
By using data from multiple states, we identify important variation in how depression 
is treated among Medicaid-enrolled youth from one state to another.  To compare 
utilization across states, the county level PPPM for each state and treatment type were used. 
ANOVA confirms that the mean number of visits for each treatment type across all states 
are not the same. While the difference in utilization rates between most pairs of states are 
significant, there are cases where the difference is not significant.  Further research is 
needed to understand the key sources of the variation in both the utilization of depression 
medication and the likelihood that a youth receives first-line psychosocial/psychotherapy 
services. 
There are trends over time across all states as well. The PPPY medication filled 
increased over time in most states, while the treated prevalence only increases in half of 
the states.  While PS utilization only increases in five states, these trends are overall 
consistent with other research for the general population that show an increase in mental 
health diagnoses and office visit utilization from 1995 to 2010[135, 136].  
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One limitation of this study was reliance on claims data to infer healthcare outcome 
measures. The MAX files only include claims that have been submitted for reimbursement. 
Therefore, estimates on the healthcare utilization may be biased where certain subgroups 
have difficulty in maintaining Medicaid coverage, lack of access, or are susceptible to 
particularly disparate utilization [137]. Furthermore, Medicaid MAX files can have data 
quality issues, especially for states with large populations on managed care[138, 139]. 
Based on the standards in the Mathematica Policy Brief, the data quality for three states in 
our sample did not meet the quality standards.  These are Florida in 2008 and 2009, 
Minnesota in 2007, 2008 and 2009, and New York in 2010 for the Drug Record 25,26.  
Another limitation is in the estimation of utilization rates for psychological services and 
medication. Procedure codes for psychological services have been only uniformly used 
after 2005, with some states being slower adopters of the uniform coding system.  Also, 
some of the medications prescribed for depression are also used to treat other co-morbid 
mental health conditions, thus there could potentially be over estimation of the medication 
utilization.  
In spite of these limitations, this study provides the most comprehensive examination 
of depression treatment among Medicaid-enrolled adolescents.  We find that treated 
prevalence and service utilization are lower for the Medicaid population than has been 
reported in other studies and reports for the general population.  This indicates that 
depression is likely under-diagnosed in this vulnerable population and that even those 
adolescents who are diagnosed may not be receiving adequate care. 
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CHAPTER 5. HEALTHCARE OUTCOME MEASUREMENTS 
FOR MEDICAID-ENROLLED CHILDREN DIAGNOSED WITH 
DEPRESSION 
5.1 Introduction 
Depression is frequently undertreated, with many adolescents and adults not 
receiving minimally adequate treatment [133, 134].  In the Medicaid population 
specifically, treated prevalence rates are lower than expected (see chapter 4), only 59% of 
youth with a new diagnosis of depression receive adequate psychotherapy and only 13% 
receive adequate medication [120].  Studies have shown that delaying treatment for 
adolescent depression can result in higher rates of severe health outcomes and overall 
higher treatment costs [140].  For adults, remission rates are higher for patients whose 
depression remains untreated for more than six months after diagnosis[141]. 
There are many studies in the literature that demonstrate the impact of depression on 
health outcomes and healthcare expenditure for comorbid health conditions.  Individuals, 
especially adolescent girls, with depression are more likely to become obese [113].  The 
relationship between childhood depression and obesity is well documented [142], and the 
duration of the pediatric depression is also a significant predictor of elevated adult BMI 
[111].  Worse health outcomes and higher costs occur when depression is combined with 
other health conditions including epilepsy[114], diabetes[143-145], adolescent cystic 
fibrosis[146], fibromyalgia [147] and mental health conditions like anxiety and 
ADHD[148-150] in the general population[151].  This is in part because treatment 
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adherence for comorbid conditions is frequently lower among the depressed population, 
particularly when there is inadequate depression treatment [152] [153]) .  By comparison, 
depressed adults are less likely to have regular primary care visits[154] and individuals 
with chronic physical health conditions and depression are more likely to use urgent 
healthcare[155, 156].   
The health outcomes for adults with depression cannot be ignored when considering 
the impact of pediatric depression. If children with depression are able to receive 
appropriate treatment, then they would not be expected to have the same comorbid effects 
and complications as depressed adults.   
In this work, we quantify and compare the healthcare utilization and expenditure for 
Medicaid-enrolled adolescents (age 12-17) with and without major depression.  Our 
analysis determines if the differences in utilization and expenditure for non-depression 
related visits between the two populations are statically significant.  We use CMS eXtract 
files from 2010-2011 for 14 states (Alabama, Arkansas, California, Florida, Georgia, 
Louisiana, Minnesota, Mississippi, North Carolina, New York, Pennsylvania, South 
Carolina, Tennessee, Texas) for the analysis.  
5.2 Methods 
5.2.1 Data Sources 
The primary data source is the Medicaid Analytic eXtract (MAX) files, consisting 
of identifiable individual-level claims data with information on service utilization and 
expenditures for all Medicaid-enrolled beneficiaries.  We used data from 2010–2012 for 
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the following fourteen states:  Alabama (AL), Arkansas (AR), California (CA), Florida 
(FL), Georgia (GA), Louisiana (LA), Mississippi (MS), Minnesota (MN), North Carolina 
(NC), New York (NY), Pennsylvania (PA), South Carolina (SC), Tennessee (TN), and 
Texas (TX).  This study was approved by CMS (Data Use Agreement #23621) and by the 
Institutional Review Board of Georgia Tech (protocol #H11287).   
5.2.2 Study Population 
The study population consists of all Medicaid-enrolled adolescents age 12 to 17. 
We differentiate among children with and without depression.  Children with depression 
are those with claims having a primary or secondary diagnosis code pertaining to major 
depression, , dysthymia, and depression not otherwise specified (identified using 
International Classification of Diseases Code ninth revision (ICD-9) codes 296.2X, 
296.3X, 300.4, and 311[125]).  Although depression can be diagnosed at any age and 
medication recommendations begin at the age of 6, the healthcare community widely uses 
the age of 12 as the lower bound for research on pediatric depression because of the 
significant increase in the rates of depression at that age [104, 126, 127].  We included 
adolescents in the study population if they had at least two recorded healthcare visits over 
the entire time period with a depression diagnosis in order to exclude patients with a 
misdiagnosis or single improperly coded visit. 
We select a comparison population of children without depression in order to 
compare the utilization and expenditure of healthcare for the two populations as provided 
in the next section. 
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5.2.3 Patient Matching 
We add the number of months that each child in the depression baseline was 
enrolled in the Medicaid system from 2010-2011 to the depression baseline data. 
For each state, we identify the non-depressed population of children age 12-17 that 
are enrolled in the Medicaid system in 2010-2011.  For each child in this set, we extract 
the demographic information that was used in the depression baseline analysis (age group, 
gender, race, urbanicity, clinical risk group and Medicaid eligibility criteria) as well as the 
number of months that they were enrolled over the two-year period.   
In order to compare the utilization and expenditures for the population of children 
with and without depression, it is necessary to create a data set that can be treated as though 
the samples are paired even though the data are from an observational data set.  Patient 
matching is a common technique that is implemented in multiple ways in the literature[157-
159] and we use the following steps to create a matched set of children where one member 
of the pair has depression and one does not. 
For each child in the population of children with a depression diagnosis, we first 
attempt to find another child in the population with the exact same characteristics but 
without a depression diagnosis. Because enrollment can bias utilization, we match 
depression vs non-depression populations assuming that there can be up to a six-month 
difference in the months of enrollment between the children in the matched pair.   
For every child with depression not yet matched using exact matching features, we 
relax one characteristic, the CRG score.  A first relaxation of CRG is that it can be +/- 1 
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from the score of the child with depression or further, it can be within a CRG group defined 
by low risk (CRG scores 1-5a) or medium-high risk (CRG scores 5b-9).  The second 
relaxation is to allow the urbanicity to vary by one level, so a child in an urban area can be 
matched with one in a suburban area, and a child in a rural area can be matched with a child 
in a suburban area.  These relaxations are added as needed for each state.   
This is similar to a breadth first search for matches because we try to match as many 
children as possible with a given criteria before relaxing any of the conditions.  The 
alternative would be a depth first search where we would try to find a match for the current 
child and would relax the criteria one at a time until a match for that particular child (if 
available) is found.  Then the process would start over again with the search for an exact 
match for the next child.  Using the breadth first approach ensures that we do not use an 
exact match for depressed child D1 as a relaxed match for depressed child D2 when there 
is not another available exact match for depressed child D1.  This ensures that we have as 
many exact matches as possible 
5.2.4 Utilization Outcome Measures 
For each child in the matched set, we extract the utilization and expenditure data 
for all non-depression claims from the MAX data in the Inpatient Table (IP), the Other 
Therapy Table (OT) and the Prescription Table (RX).  Children who are enrolled in the 
Medicaid system for a longer period of time are expected to have higher utilization, thus 
we scale the utilization and expenditure by the number of enrollment months for 
comparison between children.   
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We consider six types of care. The IP visits are all classified as hospitalizations. 
The RX table provides second type of care, medication.  We finally divide the OT visits 
into four subgroups based on the place of service: ambulatory or urgent care related visits, 
emergency department, physician office and other visits.  The third group consists of 
inpatient visits all visits that occur in hospitals (location code 22), inpatient stays (21), 
ambulances (41-42), ambulatory surgery centers (location code 24) and urgent care 
facilities (location code 20).  The fourth group is emergency department visits (location 
code 23) and the fifth group is office visits (location code 11).  The sixth group is ‘other’, 
and includes all other visits in the OT table. 
For the IP table, we use the following data elements: MDCD_PYMT_AMT, DIAG_CD_1. 
For the RX table, we use the data elements: CHRG_AMT, MDCD_PYMT_AMT, NDC, 
QTY_SRVC_UNITS. 
For the OT table, we use the following data elements: PLC_OF_SRVC_CD, CHRG_AMT, 
MDCD_PYMT_AMT, DIAG_CD_1. 
We are only interested in comparing the utilization of health care services for non-
depression related services, thus only the visits in the IP and OT tables that do not have a 
diagnosis code for depression are extracted, and only those claims in the RX table that are 
not for a depression medication are extracted.  The excluded medications are the ones used 
in the depression baseline analysis.  We extract the number of prescription units rather than 
the number of prescriptions that are filled to account for variations in the days of supply 
for each prescription fill. 
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The scaled measures are the number of visits per-enrollment-month for the IP and 
OT claims, and the number of prescription units per-patient-per-month-enrolled for the RX 
claims.   
5.2.5 Expenditure Outcome Measures 
In the Medicaid system, expenditure is reported differently with the Type of Claims. 
The claims directly billed and paid by Medicaid, for example, claims from fee-for-service 
or state-coordinated care plans, will have records for both the Charge Amount (CHRG), 
specifying the total amount of charges submitted by the care provider, and the Medicaid 
payments (MED), specifying the amount reimbursed by Medicaid. Other claims that are 
from prepaid plans or third-party managed care plans called encounters have records for 
CHRG but not for MED. Because most states included in our analysis are primarily under 
managed care, we have complete data on healthcare expenditure in the charge amount only; 
thus, charge amount is used in the derivation of the expenditure outcomes. 
The expenditure outcome measures are the total expenditure per-enrollment-month, 
and the average expenditure per-visit or prescription unit. 
5.2.6 Statistical Analysis 
We use paired Wilcoxon rank test to compare the utilization and expenditure for 
children with and without depression in each state and for each outcome measure.  Because 
we are conducting 14 independent tests, the Bonferroni correction is used to ensure that we 
do not falsely identify significant differences.  The initial alpha value is 0.1, and there are 
14 states to the corrected alpha value to determine significance is 0.0071. 
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It is also of interest to compare the results among the states.  For each pair of children, 
we compute the difference in the number of monthly visits as well as the average cost per 
visit for each type of care.  We use ANOVA and Tukey’s Test to determine if these 
utilization and cost differences vary between the states. 
All of the statistical tests were conducted using the R statistical software[160]. 
5.3 Results 
5.3.1 Study Population and Patient Matching 
Table 29 contains the number of children with and without depression enrolled 
between 2010 and 2012 with claims in the CMS database.  There are between 4 and 26 
non-depressed children available to be matched to each child with depression in each state.   
Table 29: Number of children with and without depression in each state that are 
eligible to be matched and the number of pairs that are created through the 
matching heuristic 
State 
# Children With 
Depression 




AL 14200 178109 12.5 
AR 22403 146895 6.6 
CA 140795 1800178 12.8 
FL 31776 650225 20.5 
GA 30106 339210 11.3 
LA 22552 247132 11.0 
MN 27383 131481 4.8 
MS 11666 133622 11.5 
NC 37072 309375 8.3 
NY 53564 651853 12.2 
PA 15591 397760 25.5 
SC 14864 179981 12.1 
TN 26872 249154 9.3 
TX 71528 995392 13.9 
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Table 30:Number of matches made with each relaxation and the total number of 



























AL 7083 3562 151 68 10864 77% 
AR 6419 7505 275 13 14212 63% 
CA 87904 23234 169 -- 111308 79% 
FL 19675 6593 117 -- 26389 83% 
GA 11455 9238 171 32 20896 69% 
LA 10744 3928 475 23 15170 67% 
MN 7516 9577 232 86 17411 64% 
MS 6192 2307 151 21 8671 74% 
NC 5375 10257 263 154 16049 43% 
NY 20408 23109 298 205 44020 82% 
PA 5869 5990 62 -- 11930 77% 
SC 4124 6972 219 61 11376 77% 
TN 2544 6095 174 127 8940 33% 
TX 19865 22018 601 62 42546 60% 
The percent of children with depression that can be matched to a child without 
depression using the matching features exactly tis highly variable, as is the number that can 
be matched at all.  In Tennessee, only 33% of children with depression have a match, and 
North Carolina is the second lowest with only 43% matched.  No other states have a match 
percentage that is less than 50%.  The best results are in New York and Florida, where 82% 
and 83% of children with depression are matched.   
Table 30 contains the number of children that are matched exactly and with each 
relaxation in each state. 
Because there are many children without an exact match in some states, we need to 
identify which criteria are the limiting factors.  Table 31 below contains a simple summary 
of the children that cannot be matched, and a more detailed breakdown can be found in 
Appendix D.1 Table 42.  In every state, there are more females that cannot be matched than 
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males and (except for MS) more unmatched children in urban areas than suburban or rural 
areas.  In all of the states there are more children age 15-17 that cannot be matched than 
children age 12-14, and in 9 of the states there are no unmatched 12-14-year-old children.  
The race with the most unmatched children varies by state; 9 states have the most 
unmatched white children; two states have the most unmatched black children and three 
states have the most unmatched other race children.  Across all of the states together there 
are more white children that are unmatched than any other race.   
Table 31: Number of children with depression that are unable to be matched by 
gender, race, age, and urbanicity 
 Gender Race Age Group Urbanicity 
State F M White Black Other 15 to 17 12 to 14 Urban Suburban Rural 
AL 2272 1035 1801 1401 105 3307 0 2325 753 186 
AR 5873 2312 5606 1768 811 8185 0 4533 2029 1623 
CA 17909 11563 11266 5314 12892 29472 0 28592 735 145 
FL 3563 1805 1630 1880 1858 5368 0 5061 307 0 
GA 6013 3160 4201 3961 1011 9142 31 6895 1583 678 
LA 5480 1884 3920 3122 322 7364 0 5749 1388 227 
MN 6414 3532 6720 1287 1939 9946 0 7891 1235 820 
MS 1982 995 1055 1543 379 2953 24 1061 1164 637 
NC 13614 7403 10607 8550 1860 18437 2580 18076 2813 128 
NY 6689 2823 3795 1779 3938 9512 0 8940 540 0 
PA 2543 1095 2691 668 279 3638 0 2704 710 224 
SC 2612 866 1873 1224 381 3478 0 3225 253 0 
TN 11573 6337 12633 4194 1083 16305 1605 13234 3965 711 
TX 18525 10420 7706 5416 15823 26216 2729 26569 2224 152 
Total 105062 55230 75504 42107 42681 153323 6969 134855 19699 5531 
5.3.2 Utilization and Expenditure Comparison  
Table 32 shows the median difference in utilization and expenditure between the 
depression and non-depression populations in all three major categories as well as for the 
total charges per patient per month enrolled in every state.  The median values for the 
 106 
depression (Table 47) and non-depression (Table 48) populations individually are 
presented in Appendix D.  
Table 32: Median of the difference in the number of visits (or units for RX) and 
charge amounts per patient per month enrolled between the depression and the non-















AL -4.1 -$718.20 0.00299 $76.73 -0.2 $37.09 -$604.40 
AR -7.0 -$900.10 0.00439 $25.82 20.3 $65.79 -$808.50 
CA -0.8 -$157.80 0.00608 $154.60 1.4 $16.90 $13.60 
FL -4.1 -$760.10 0.00417 -$102.50 11.7 $34.49 -$828.10 
GA -4.4 -$583.30 -0.00212 -$44.50 3.5 $15.31 -$612.50 
LA -6.1 -$985.00 0.00423 $6.80 17.0 $60.80 -$917.00 
MN -6.2 -$360.80 0.00382 $17.50 18.1 -$28.50 -$371.80 
MS -3.7 -$480.50 0.00474 $104.80 -30.8 $23.50 -$352.30 
NC -4.8 -$418.50 0.00049 $24.54 4.0 $37.76 -$356.20 
NY -4.6 -$415.90 0.00510 $1.68 452.5 $1,300.00 $885.90 
PA -4.7 -$390.20 0.00247 $54.53 9.1 $43.97 -$291.70 
SC -3.8 -$553.10 0.00241 $37.65 10.3 $30.11 -$485.30 
TN -5.2 -$221.20 0.00358 $19.11 6.3 $30.41 -$171.70 
TX -11.9 -$1,131.00 -0.00090 -$57.90 7.9 $128.40 -$1,060.00 
Appendix D Table 49 contains the number of pairs of children in each state where 
at least one child in the pair has IP visits as well as p-values for the one-sided Wilcoxon 
tests with an alternative hypothesis that the utilization/charge for the depression population 
is greater than the utilization/charge for the non-depression population.  After using the 
Bonferroni correction with an initial α = 0.1 for multiple hypothesis testing, our new alpha 
value is α = 0.0071.  Even with this conservative alpha value, there are significantly more 
IP visits made by children in the depression population than by children without depression 
in every state. The charge per-patient per-month for IP visits is also significantly higher for 
children with depression in all 14 states.   
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Similarly, the utilization in units per patient per month enrolled and charge amounts 
per unit of prescription medication are higher for children with depression than for children 
without depression in every state.  The p-values for the one-sided Wilcoxon test are 
included in Appendix D Table 49.  
The number of pairs of children with each type of OT visits as well as the 
significance of the difference in utilization and charge amounts are presented in Appendix 
D  Table 50 and Appendix D Table 51 .  For Hospital/Urgent Care/Ambulance claims, 
children with depression in every state have significantly more visits and higher charges 
than children without depression.  The opposite is true for ED and Other claims; there are 
significantly more visits and higher charges for children without depression than for those 
with depression in all fourteen states.  For Office visits, the results vary by state.  In 
Alabama, there are significantly more visits for children with depression, but the charges 
are not significantly higher. The number of visits is not greater but the charge amount is in 
Mississippi, New York, and Tennessee.  Finally, in Arkansas, Minnesota, South Carolina 
and Texas, neither the utilization nor the charge amount for Office visits is significantly 
greater for children with depression. 
For the combined OT visits per patient per month enrolled, the median of the 
differences in utilization and expenditures between the depression and non-depression 
population are negative in every state (indicating that the non-depression population 
generally has more visits and higher charges). The magnitude of the differences in 
utilization has limited variation across the states (11 of the 14 states have a difference 
between -3 and -6 visits).  There are greater differences in the charge amounts.  California 
has the smallest difference and Texas has the largest in both the visits (-0.795 and -11 visits 
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per patient per month enrolled) and the charge amount (-$157 and -$1131 per patient per 
month enrolled). 
Based on the Wilcoxon test, the total charge amount per patient per month enrolled 
is significantly different between the depression and non-depression populations in every 
state.  The charges are significantly higher for the depression population in California, 
Florida, New York, and Pennsylvania.  The largest median difference is in New York 
($885) and California is the lowest ($13).  
Using the Kruskall-Wallis test, we reject the null hypothesis (p-value < 2.2e-16) that 
the median utilization and expenditure for each type of service are the same in all of the 
states.  Similarly, ANOVA rejects the null hypothesis, in tests for each type of service, that 
the mean utilization and cost is the same across all of the states.  The number of pairs of 
states in which the difference is statistically significant varies by visit type.  There are 91 
pairs of states that are compared using Tukey’s Test.  For IP claims, there are significant 
differences in the per-patient monthly visits in 37 pairs of states, but only 5 pairs of states 
with significantly different charge amounts (California is different from Florida, Georgia, 
Louisiana, New York and Texas).  New York is significantly different from every other 
state for both the number of units and the charge amounts for prescription medication, and 
no other pairs of states have significant differences.  When comparing total OT utilization 
and expenditures, there are 64 states with differences in utilization and 37 with differing 





In every state, there are at least 4 children in the non-depression baseline population 
per child in the depression baseline population, with the majority of the states having 
between 10 and 20 non-depression children available to be matched with each child with 
depression.  However, there are still thousands of children with depression that we are 
unable to match to a similar child without depression using the specified matching criteria.  
The percent of children that we are able to match in each state is not strongly correlated 
with the number of available matches per child with depression (correlation = 0.49).  This 
indicates that the total number of children available for matching is not the limiting factor 
in whether or not we are able to identify suitable matches.   
In Tennessee and North Carolina in particular, we have over 50% of the depression 
population that remains unmatched and is therefore excluded from this comparison 
analysis.  The largest unmatched group in Tennessee (44% of the unmatched children) is 
white children age 15-17 in urban and areas.  In North Carolina, 44% of the unmatched 
children with depression are black and white females age 15-17 living in urban areas, with 
an additional 22% of the unmatched children being males with the same characteristics.  
Because of the population density of urban areas, it is not surprising that in terms of 
absolute numbers that is where the largest percent of unmatched children live.   
While the average differences in IP utilization are significant for all of the states 
except for North Carolina and the median difference is significant in all of the states, the 
magnitude is relatively small and children with depression have less than 0.65 additional 
inpatient stay per year on average than their non-depression counterparts.  When we 
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consider the difference over six years to account for the age range we consider (12-17), 
however, the seemingly small differences in utilization adds up and in 7 of the 14 states 
there would be on average approximately 2 more inpatient visits per child with depression.   
The median charge for inpatient visits in every state is also higher for children with 
depression.  With both a higher median utilization and charge amount, the total cost for 
inpatient care for children with depression is higher than that for children without 
depression. 
Based on the paired Wilcoxon test, there are significantly more RX units and fills in 
every state for the depression population than for the non-depression population.  Based on 
the paired t-test, however, children with depression only have significantly more 
prescriptions units filled than children without depression in half of the states even though 
the number of fills is significantly higher in every state.  Because the number of time 
depression children had prescriptions filled is significantly higher even when the units of 
medication is not, we can determine that the units per prescription fill is lower on average 
in the states without significant differences in the number of units.  This could mean that 
children have to have prescriptions for medications that they need filled more frequently, 
which is less convenient and may lead to missed medication days[161] if there is a gap 
between when one prescription runs out and when the refill can be picked up.  
The average difference in prescription units for the depression and non-depression 
populations in 13 of the states ranges from 1.7 (California) to 21 (Arkansas) additional 
units per month for children with depression, which is less than one additional unit per day.  
The extremely high difference in New York of 512 units per month is approximately 16 
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units per day different for each child with depression.  Further study would be needed to 
understand why the average difference is so high in New York alone, because the number 
of prescriptions fills is not disproportionality large in New York.  In addition, as shown in 
chapter 4, RX utilization for depression treatment is lower in New York from 2005-2012 
than in almost any other state.   
Children with depression have significantly higher severe outcome rates that require 
outpatient services at hospitals, in ambulances, and in urgent care centers in all 14 states.  
California, Louisiana and Minnesota have the greatest differences with at least one 
additional visit per month on average.  These same three states have the highest difference 
in ED utilization as well, averaging more than two additional visits per depression patient 
per month.  Having such high utilization of outpatient hospitals, urgent care facilities, and 
emergency departments indicates that these children are likely not receiving adequate 
preventative care.  The costs per patient per month for these severe outcome treatments are 
also higher. 
Utilization of office visits and “Other” OT visits are also significantly larger on 
average for the depression population for all states except for Pennsylvania (office only) 
and Texas.  Even though the average utilization is not significantly higher for depression 
children in those two states, the median utilization is.   
Overall, we see that there is higher utilization of health care services for children 
with depression.  Even in the cases where the average utilization is not significantly larger, 
the median utilization is significantly larger for the depression population.  The magnitude 
of the difference in utilization between the depression and non-depression populations 
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varies across the states, which could be the result of state level health care policies or in 
part because of the effectiveness of depression treatment.  The same is true for the 
expenditures in every state.  The Medicaid charge amounts are consistently higher per 
patient per month enrollment among the population with depression. 
These utilization and expenditure differences confirm that, separate from their 
depression treatment, children with depression require more frequent and more costly care.  
Therefore, it would be advantageous from both a health and a cost perspective for as many 
as children as possible to receive an early diagnosis and treatment to increase the likelihood 
of entering remission.   
Limitations 
The primary limitation in this study is the reduction of the sample size due to the 
number of children with depression that cannot be matched to a child without depression 
given the matching constraints.  In addition, the scope of the study is limited to two years.  
With additional years of data, a longitudinal approach to track patients from age 12 to 17, 
or a longer-term analysis where a larger percent of the children may be enrolled for multiple 
years could be conducted.  Finally, it is possible that there are children in the non-
depression population that have mental health conditions other than major depression, 
dysthymia or depression not otherwise specified.  Anxiety, bipolar disorder, and other 





CHAPTER 6. CONCLUSION 
Asthma and depression are two of the most prevalent chronic pediatric health 
conditions in the United States and adequate treatment of these conditions is a critical factor 
in improving the health outcomes of the children who are affected by them.  This thesis 
serves two purposes: to quantify spatial access to pediatric asthma care and to analyze the 
differences in healthcare utilization between children with and without depression among 
the Medicaid population. 
We began by computing the spatial access to pediatric asthma specialist care.  By 
using an optimization model to assign patients to providers, we are able to account for 
practical system constraints and obtain the average driving distance using the US highway 
network for children in each tract to receive asthma specialist care.  This access measure is 
more accurate than measures obtained using other common methods, and is also 
straightforward to understand.  We find that there is significant variation in the distribution 
of the access to care both within individual states and between the states in the study.  
Therefore, while access to asthma specialist care is, overall, better in some states than 
others, there is room for improvement in every state.  After computing the estimates of 
spatial access to asthma specialist care, we use them in regression models for two states to 
demonstrate and quantify the significance of that access on the rate of severe health 
outcomes.  We find that access to specialist care is statistically significant when estimating 
both ED and Hospitalization rates, and that the variation of the distance to receive care 
within each county as well as geographic access to primary care are also significant.  These 
spatial access measures are significant on their own and in their interactions with other 
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predictors.  Therefore, a state by state analysis of potential interventions will be necessary 
because the improvements to one type of access or another will not have a uniform impact 
on the children in different areas. 
After establishing the significance of geographic access to both primary and 
specialist care, we expand the optimization assignment model to conduct a seasonal 
analysis that includes both primary and specialist providers and also divides the patient 
population into children with Medicaid and children who are not on Medicaid. Among 
primary care providers in every state, there is very little variation in the percent of each 
provider’s caseload that is allocated to pediatric asthma visits.  The same is not true for 
asthma specialist providers.  The percent of each specialist’s caseload allocated to pediatric 
asthma ranges from less than 2% to almost 70%. 
The unexpected result from the model is that there are no significant seasonal 
variations in access to either primary or specialist care in spite of the seasonality of the 
demand for asthma visits.  Where there are significant differences in access to the different 
types of care.  There are numerous census tracts in each state in which all visits that should 
be met by an asthma specialist are instead assigned to a primary care provider because of 
insufficient specialist capacity.  In addition, Medicaid patients requiring specialist care 
have the greatest driving distances to receive care in almost every state.  Because of the 
lack of seasonality of access to care, seasonal interventions will be insufficient.  In order 
to improve access to care, permanent improvements to the health care network (such as 
increasing Medicaid acceptance, locating new providers, or increasing asthma training 
among primary care providers) will be necessary.   
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To begin our analysis of pediatric depression, we established a baseline for pediatric 
depression in the Medicaid population for the years 2005 to 2012.  Other sources provide 
prevalence estimates for particular subsets of the pediatric population based on one or two 
demographic factors; however, they do not provide prevalence information for children 
specifically in the Medicaid population.  By using diagnosis codes, treatment procedure 
codes, and national drug codes to select records from the MAX files, we identify the 
population of children age 12-17 with Medicaid insurance that have depression and 
compute their utilization of depression treatment.  One of the most important findings is 
that the treated prevalence of depression in the Medicaid population is lower than 4% 
across the entire period for every state except Arkansas and North Carolina, while the 
CDCs prevalence estimates for depression rates in the total adolescent population have a 
lower bound of 4%.  This under-diagnosis of depression in the Medicaid population is of 
particular concern because these adolescents have higher risk factors for depression.  The 
utilization of depression treatment services is highly variable between the states, indicating 
that children in different states do not receive the same types of depression care.  In 
addition, the overall use of psychological service is insufficient to meet the minimally 
adequate treatment guidelines, while prescription use increases in every state over the 
entire study period.  The low prevalence and psychological service rates suggest that 
diagnosis and treatment of pediatric depression among the Medicaid population should be 
improved. 
In the final study of the thesis, we build on the depression baseline and analyze the 
differences in non-depression health care utilization and cost between the depression and 
non-depression populations in the MAX files.  By scaling each patient’s visits/prescription 
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units and charge amounts by months of enrollment, we are able to compare the utilization 
and expenditures of children over a two-year period even when they are enrolled in the 
system for variable amounts of time.  From the Wilcoxon test to compare the median 
utilization and charge amounts between the two groups in each state, we find that children 
with depression have both higher utilization and higher charge amounts than children 
without depression for some service types (IP, RX, OT-Hospitalizations) but not for other 
service types (OT-ED, OT-Other).   
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APPENDIX A. ADDITIONAL INFORMATION FOR CHAPTER 2 
The results of the logistic regressions for estimating severe asthma outcomes are 
shown below in Table 33 for Georgia and Table 34 for North Carolina, with the R square 
values in Table 35. 
Table 33. GA Regression Results.  For the categorical age variable, age 15 to 17 is 
omitted as the reference variable. The reference value for numeric variables is 0. 
Highlighted rows indicate access variables. 
 ED Visits Hospitalizations 






(Intercept) -3.068(0.033) < 0.001 -6.214(0.108) < 0.001 
Age 5-9 0.554(0.036) < 0.001 1.606(0.106) < 0.001 
Age 10-14 0.974(0.039) < 0.001 1.633(0.111) < 0.001 
MedianIncome -0.375(0.023) < 0.001 -0.479(0.038) < 0.001 
AdultEducation -0.187(0.019) < 0.001 -0.120(0.051) 0.02 
Nonhospital 0.127(0.005) < 0.001 0.087(0.015) < 0.001 
SpecialistDistance 0.029(0.017) 0.102 -0.057(0.047) 0.226 
PrimaryDistance 0.013(0.027) 0.648 -0.198(0.047) < 0.001 
VarSpecialistDistance -0.005(0.021) 0.808 0.050(0.052) 0.337 
PrimaryDistance: 
AdultEducation 
0.061(0.023) 0.009 0.125(0.041) 0.003 
VarSpecialistDistance: 
AdultEducation 
-0.165(0.029) < 0.001 -0.200(0.051) < 0.001 
PrimaryDistance:Age 5-9 -0.157(0.027) < 0.001   
PrimaryDistance:Age 10-14 -0.145(0.029) < 0.001   
SpecialistDistance: 
PrimaryDistance 
-0.070(0.017) < 0.001 -0.134(0.047) 0.005 
VarSpecialistDistance:      
Age 10-14 
0.108(0.032) 0.001   
PrimaryDistance: 
MedianIncome 
-0.104(0.020) < 0.001   
SpecialistDistance: 
MedianIncome 
0.115(0.020) < 0.001   
SpecialistDistance: 
AdultEducation 
0.083(0.017) < 0.001   
VarSpecialistDistance: 
MedianIncome 
-0.119(0.028) < 0.001   
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Table 34.  NC Regression Results.  For the categorical age variable, age 15 to 17 is 
omitted as the reference variable. The reference value for numeric variables is 0.  
Highlighted rows indicate access variables.  









(Intercept) -1.727(0.018) < 0.001 -4.726(0.063) < 0.001 
Age 5-8 0.584(0.023) < 0.001 1.974(0.063) < 0.001 
Age 9-14 0.165(0.021) < 0.001 0.485(0.065) < 0.001 
MedianIncome -0.088(0.013) < 0.001 -0.278(0.036) < 0.001 
AdultEducation 0.071(0.012) < 0.001 0.043(0.033) 0.2 
NumHospitals 0.120(0.007) < 0.001 0.053(0.037) 0.1524 
SpecialistDistance 0.050(0.016) 0.002 0.072(0.036) 0.045 
VarSpecialistDistance -0.184(0.023) < 0.001 0.218(0.046) < 0.001 
PrimaryDistance 0.066(0.018) < 0.001 -0.094(0.042) 0.029 
PrimaryDistance:Age5-8 0.061(0.021) 0.005 0.098(0.039) 0.013 
PrimaryDist:Age 9-14 -0.052(0.019) 0.009   
PrimaryDist: AdultEducation -0.030(0.014) 0.033 -0.089(0.042) 0.035 
SpecialistDistance: MedianIncome -0.061(0.012) < 0.001   
VarSpecialistDist: MedianIncome -0.120(0.018) < 0.001   
PrimaryDistance: MedianIncome 0.101(0.014) < 0.001 -0.086(0.048) 0.073 
SpecialistDistance: Age5-8 -0.060(0.025) 0.017   
VarSpecialistDistance: Age5-8 0.156(0.037) < 0.001   
VarSpecialistDistance: 
AdultEducation 
-0.156(0.015) < 0.001   
PrimaryDist: SpecialistDist   0.299(0.046) < 0.001 
SpecialistDistance: AdultEducation   -0.154(0.039) < 0.001 
SpecialistDistance: 
VarSpecialistDistance 
  -0.095(0.031) 0.002 
PrimaryDistance:NumHospitals   0.064(0.023) 0.0074 
VarSpecialistDistance: 
PrimaryDistance 
  -0.318(0.056) < 0.001 
MedianIncome: AdultEducation   -0.079(0.029) 0.007 
MedianIncome: NumHospitals   0.241(0.032) < 0.001 
AdultEducation: NumHospitals   0.302(0.048) < 0.001 




Table 35 : Pseudo-R square for logistic regression with replications as provided by 
the selected fitted models for all four cases 
 ED Visits Hospitalizations 
Georgia 64.2% 42.7% 
North Carolina 41.8% 68.3% 
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APPENDIX B. ADDITIONAL INFORMATION FOR CHAPTER 3 
B.1  Season Identification 
Because the geographic scope of the project is limited to the Southeast United States, 
it is assumed that the seasons start at the same time in each state.  We identify the start and 
end dates of each season using the public-school calendars in each state[162].  The start 
and end dates of each academic semester, fall and spring, are collected for each state for 
2010 and the most common date for each season is selected.  Table 36 below shows the 
week number (where week 1 starts on the first Monday of January) for the academic year 
seasons.   
Table 36: Week numbers corresponding to the start and end of the academic year 
seasons 
 AL AR FL GA LA NC MS SC TN TX 
Model 
Selection 








36 34 35 33 33 35 34 34 34 34 34 
Fall End 52 52 52 52 52 52 52 52 52 52 52 
The fall season has 18 weeks, the spring season has 22 weeks, and the summer season 
has 12 weeks.  These seasons will be used in both the provider capacity and the patient 




B.2  Provider Type 
The National Uniform Claims Committee [47] maintains the list of standard Taxonomy 
Codes that identify the different provider types.  From the complete list of Taxonomy 
Codes, we extract the subset that identify primary care physicians and asthma specialists.  
The codes for primary care providers are based on the work of Gentilli et al. [163] and 
include those for Pediatricians, Pediatric Nurse Practitioners, Family Medicine and 
Internal Medicine.  The set of codes for asthma specialists includes those for 
Pulmonologists, Pediatric Pulmonologists, Allergists, and Pediatric Allergists.  The full 
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B.3  Distance Computations 
We used version 10.5 of the ArcMap software to compute all of the distances that 
are needed for the model.  Locations are loaded into the software using latitude and 
longitude coordinates.  The software computes distances between specified locations using 
the US Highway Network rather than a distance estimate such as the Euclidean or 
Manhattan distance.  This is an important distinction because using the highway network 
to compute distances provides the distance that an individual would have to drive to get 
from one location to another using the actual roads available, which is a much more 
accurate representation of the real distances traveled.   
B.3.1 Provider to Tract Distances 
Our access models assume the travel distance to be the cost of matching a patient 
visit to a provider.  These distances are computed using ArcMap10 and the US Highway 
Network.  It is assumed that all patients in a particular census tract are located at the 
centroid of that tract.  We use the ArcMap software rather than a distance estimate 
(Euclidean, Manhattan etc.) so that the optimization model’s output will be driving 
distances to receive care.  
ArcMap uses latitude and longitude coordinates to locate the origins and 
destinations.  These values are readily available for census tract centroids from the Tiger 
Files [164].  The NPI database lists the street address of each provider, and the 
corresponding latitude and longitude are obtained by using the Texas A&M Geocoding 
Service [94].   
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For each state, the origin set consists of all census tracts in the state and the 
destination set contains the complete list of providers (primary and specialist care) that see 
asthma patients.  We compute the distance between each origin and destination pair, and 
the distance between census tract i and provider j is used as the cost to assign 1 visit from 
census tract i to provider j in the optimization model.   
B.3.2 Neighboring Census Tracts 
For each state, both the origin and the destination set is the list of census tract 
centroids.  The output from the ArcMap software is the distance between each pair of 
census tract centroids.  Two tracts are considered to be neighbors if the distance between 
their centroids is less than 10 miles, so we create a binary matrix indicating which pairs of 
tracts are neighbors, and a data matrix with the distances between only those tracts that are 
neighbors to use as inputs for the optimization model. 
B.3.3 Driving Distance Guidelines for Identification of Unmet Need  
The United States Department of Health and Human Services has published access 
guidelines for primary and specialist care for the Medicaid population in some states[100].  
There are not guidelines for all of the states considered in this work, and there are large 
differences in the guidelines for different states even when they do exist.  Table 38 below 
shows the access guidelines as presented in Appendix A of the Department of Health and 
Human Services Report. 
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Table 38: US Government Medicaid access standards for Urban and Rural Primary 
and Specialist care 
State Primary Care Specialist Care 
GA 
Urban: Two providers within 8 miles 
Rural: Two providers within 15 miles 
Urban: One provider within 30 miles 
Rural: One provider within 45 miles 
MS 
Urban: Two providers within 30 miles 
Rural: Two providers within 60 miles 
No Standard 
TN 
Urban: 1 provider within 20 miles 
Rural: 1 provider within 30 miles 
1 provider within 60 miles for 75% of 
enrollees and 1 provider within 90 
miles for all enrollees 
B.4  Providers Other than Primary and Asthma Specialists 
In each of the seven states, there are over 100 providers in the Medicaid MAX files 
that have at least 11 different claims per year reported with diagnosis codes that are not in 
the categories for either primary or asthma specialist providers.  There are 79 different 
physician classifications (from the NUCC Taxonomy Codes) with physicians that have 
asthma claims.  Many of these providers will not realistically treat asthma patients, and 
only 11 of the classifications have at least 15 providers with asthma records in one or more 
states.   
Table 39 below lists the number of physicians and the percent of ‘other Medicaid’ 
physicians in that category by type and classification for the classifications with more than 
15 providers or 10% of the total ‘other Medicaid’ providers for at least one state.   
The number of the other Medicaid providers in each state may also provide another 
measure of the quality of the data in each state and/or the types of providers that may be 
actually treating asthma patients.  For example, it is unlikely that a medical supplier is 
providing asthma treatment, and there are between 9 and 152 of these providers with 
asthma claims in each state. Nurse Practitioners (without a pediatric specialty), however, 
are likely to treat children with asthma and there are 286 of these providers in MS.  In 
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addition, the number of ‘other’ providers is not directly related to the size of the population 
in the state- MS has 1,050 and TX only has 159. 
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Table 39: Other Medicaid providers that have asthma visits 
  AL AR GA LA MS NC TN 
Total ‘Other’ Medicaid Providers 256 114 478 690 1059 555 426 
Type Classification # % # % # % # % # % # % # % 
Suppliers 
Durable Medical Equipment 
& Medical Supplies 
61 24% 9 8% 49 10% 66 10% 152 14% 109 20% 43 10% 
Allopathic & 
Osteopathic Physicians 
Emergency Medicine 54 21% 25 22% 60 13% 71 10% 92 9% 77 14% 50 12% 
Other Service 
Providers 
Specialist 34 13% 9 8% 33 7% 38 6% 26 2% 20 4% 53 12% 
Allopathic & 
Osteopathic Physicians 
Radiology 17 7% 11 10% 36 8% 45 7% 54 5% 25 5% 20 5% 
Physician Assistants & 
Advanced Practice 
Nursing Providers 
Nurse Practitioner 12 5% 5 4% 24 5% 60 9% 286 27% 3 1% 48 11% 
Ambulatory Health 
Care Facilities 
Clinic/Center 11 4% 16 14% 31 6% 36 5% 58 5% 31 6% 5 1% 
Allopathic & 
Osteopathic Physicians 
Pediatrics 10 4% 4 4% 48 10% 17 2% 8 1% 12 2% 13 3% 
Suppliers Pharmacy 10 4% 0 0% 3 1% 0 0% 7 1% 82 15% 3 1% 
Hospitals General Acute Care Hospital 3 1% 1 1% 67 14% 200 29% 224 21% 93 17% 95 22% 
Physician Assistants & 
Advanced Practice 
Nursing Providers 
Physician Assistant 1 0% 0 0% 30 6% 10 1% 9 1% 2 0% 13 3% 
Student, Health Care 
Student in an Organized 
Health Care 
Education/Training Program 
1 0% 13 11% 0 0% 3 0% 4 0% 1 0% 6 1% 
Allopathic & 
Osteopathic Physicians 
Pathology 1 0% 0 0% 0 0% 3 0% 0 0% 1 0% 0 0% 
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B.5  Additional Statistical Test Results for Unmet Need 
The results of the statistical tests to determine for which pairs of states the difference 
in unmet need is significantly different for each provider type in a rural and urban setting 
are shown in the tables below.  Significant differences have p-values that are highlighted 
in green. 
Table 40: Tukey Test results for unmet need (percent of visits that cannot be 
assigned to a provider within an acceptable distance) in rural areas in each state 
  MD Rural MDM Rural S Rural SM Rural 
  diff p-value diff p-value diff p-value diff p-value 
AR-AL -0.0027 1.0000 0.0237 0.5171 -0.0135 0.9879 -0.1070 0.0172 
GA-AL -0.0418 0.3784 0.0052 0.9998 -0.0770 0.0007 -0.1274 0.0039 
LA-AL -0.0170 0.9959 0.0366 0.3977 -0.0593 0.1983 -0.1694 0.0040 
MS-AL -0.0369 0.7448 0.0163 0.9553 -0.0581 0.1304 -0.1629 0.0017 
NC-AL 0.0016 1.0000 0.0342 0.1223 -0.0245 0.8172 -0.0608 0.5165 
TN-AL -0.0332 0.7912 0.0206 0.8432 -0.0619 0.0583 -0.0729 0.5134 
GA-AR -0.0390 0.2015 -0.0185 0.6148 -0.0636 0.0004 -0.0204 0.9899 
LA-AR -0.0143 0.9971 0.0129 0.9851 -0.0458 0.3670 -0.0624 0.7239 
MS-AR -0.0341 0.6853 -0.0074 0.9986 -0.0446 0.2521 -0.0559 0.7122 
NC-AR 0.0044 1.0000 0.0104 0.9497 -0.0110 0.9864 0.0462 0.5565 
TN-AR -0.0305 0.7315 -0.0031 1.0000 -0.0485 0.1118 0.0341 0.9512 
LA-GA 0.0248 0.9560 0.0314 0.4943 0.0177 0.9870 -0.0421 0.9542 
MS-GA 0.0049 1.0000 0.0111 0.9897 0.0189 0.9678 -0.0356 0.9649 
NC-GA 0.0434 0.1258 0.0290 0.1264 0.0526 0.0103 0.0666 0.2112 
TN-GA 0.0086 0.9996 0.0154 0.9292 0.0151 0.9863 0.0545 0.7214 
MS-LA -0.0199 0.9929 -0.0203 0.9387 0.0012 1.0000 0.0065 1.0000 
NC-LA 0.0186 0.9882 -0.0024 1.0000 0.0348 0.7060 0.1086 0.1148 
TN-LA -0.0162 0.9972 -0.0160 0.9770 -0.0027 1.0000 0.0965 0.3664 
NC-MS 0.0385 0.5646 0.0179 0.8808 0.0336 0.6160 0.1021 0.0770 
TN-MS 0.0037 1.0000 0.0043 1.0000 -0.0039 1.0000 0.0900 0.3398 
TN-NC -0.0348 0.6066 -0.0136 0.9539 -0.0375 0.4018 -0.0121 0.9998 
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Table 41: Tukey Test Results for unmet need (percent of visits that cannot be 
assigned to a provider within an acceptable distance) in urban areas in each state 
  MD Urban MDM Urban S Urban SM Urban 
  diff p-value diff p-value diff p-value diff p-value 
AR-AL 0.0294 0.0001 0.0488 0.0000 0.0155 0.1714 0.0284 0.0052 
GA-AL -0.0115 0.1526 0.0003 1.0000 -0.0244 0.0000 -0.0703 0.0000 
LA-AL 0.0705 0.0000 0.0773 0.0000 0.0306 0.0000 -0.0164 0.1131 
MS-AL -0.0056 0.9693 -0.0076 0.9409 0.0088 0.7558 -0.0514 0.0000 
NC-AL -0.0026 0.9975 0.0058 0.9279 -0.0078 0.5663 -0.0412 0.0000 
TN-AL -0.0067 0.8049 0.0036 0.9959 -0.0074 0.7030 -0.0604 0.0000 
GA-AR -0.0409 0.0000 -0.0485 0.0000 -0.0398 0.0000 -0.0987 0.0000 
LA-AR 0.0410 0.0000 0.0285 0.0032 0.0152 0.1891 -0.0448 0.0000 
MS-AR -0.0350 0.0000 -0.0563 0.0000 -0.0067 0.9642 -0.0798 0.0000 
NC-AR -0.0320 0.0000 -0.0429 0.0000 -0.0232 0.0012 -0.0696 0.0000 
TN-AR -0.0361 0.0000 -0.0452 0.0000 -0.0228 0.0030 -0.0888 0.0000 
LA-GA 0.0820 0.0000 0.0770 0.0000 0.0550 0.0000 0.0538 0.0000 
MS-GA 0.0059 0.9411 -0.0079 0.8991 0.0332 0.0000 0.0189 0.0843 
NC-GA 0.0089 0.2385 0.0055 0.8910 0.0166 0.0002 0.0290 0.0000 
TN-GA 0.0048 0.9179 0.0033 0.9951 0.0170 0.0008 0.0098 0.4730 
MS-LA -0.0761 0.0000 -0.0849 0.0000 -0.0219 0.0042 -0.0350 0.0000 
NC-LA -0.0731 0.0000 -0.0715 0.0000 -0.0384 0.0000 -0.0248 0.0001 
TN-LA -0.0772 0.0000 -0.0737 0.0000 -0.0380 0.0000 -0.0440 0.0000 
NC-MS 0.0030 0.9982 0.0134 0.3877 -0.0165 0.0369 0.0102 0.7413 
TN-MS -0.0011 1.0000 0.0111 0.6690 -0.0161 0.0675 -0.0090 0.8637 
TN-NC -0.0041 0.9551 -0.0023 0.9993 0.0004 1.0000 -0.0192 0.0027 
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APPENDIX C. ADDITIONAL INFORMATION FOR CHAPTER 4 
C.1  3M Clinical Risk Group (CRG) Classification 
A Clinical Risk Group (CRG) is assigned to each Medicaid patient for each year 
using the 3M Clinical Risk Grouping Software. CRGs relate an individual’s utilization 
history to the amount and type of healthcare resources they will use in the future. To assess 
how expenditure changes over time, only one year of history was processed at a time. 
The software assigns one of 1,080 possible CRGs to each patient primarily using 
the diagnosis codes, procedure codes, and national drug codes (NDCs) found in their 
claims. These codes are used to determine Episode Diagnostic Categories (EDCs) and 
Episode Procedure Categories (EPCs). EPCs are not heavily used by the software in order 
to prevent organizations from being incentivized to avoid enrolling people with a history 
of major procedures and because poor-quality care may result in procedures that are 
otherwise avoidable. EDCs, on the other hand, are used to determine a patient’s Primary 
Chronic Disease, which is the most significant chronic disease actively being treated, and 
its severity for each organ system. This is done in a hierarchical fashion so that more severe 
chronic conditions and more recent or recurrent conditions are given priority. A severity 
level, which describes the disease’s progression and the need for future medical services, 
is also determined for each Primary Chronic Disease based on the sites of service and other 
EDCs and EPCs. Finally, a patient is assigned to the CRG with the most serious status for 
which they qualify based on their Primary Chronic Diseases, EDCs, and EPCs. The first 
digit of this CRG represents a patient’s status, and the last digit represents their severity 
within that status. 
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The 3M Software also further combines CRGs into three levels of Aggregated 
Clinical Risk Groups (ACRGs). ACRG 1 is the least aggregated and ACRG 3 is the most. 
In these aggregations, the first digit is maintained, but the digit representing severity may 
be adjusted. 
In our analysis, we consider only the first digit of a patient’s ACRG 1 code unless 
that digit is ‘5’. CRG Status 5 is divided into two groups based on whether the patient’s 
condition, as described by their assigned ACRG 1, is episodic or lifelong. 
C.1  Stratified Depression Visits 
Figure 23 through Figure 34 below show the breakdown of depression visits in each 
state by stratification.  The values represent the percent of total depression visits each strata 
subcategory utilized in a single year, where visits are classified as any depression related 
behavioral therapy treatments, emergency room uses, or medication fills. 
 
Figure 23: Depression visits by strata in Alabama for 2012 
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Figure 24: Depression visits by strata in Arkansas for 2012 
 
 
Figure 25: Depression visits by strata in Florida for 2012 
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Figure 26: Depression visits by strata in Georgia for 2012 
 
  
Figure 27: Depression visits by strata in Louisiana for 2012 
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Figure 28: Depression visits by strata in Minnesota for 2012 
 
  
Figure 29: Depression visits by strata in Mississippi for 2012 
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Figure 30: Depression visits by strata in North Carolina for 2012 
 
  
Figure 31: Depression visits by strata in New York for 2012 
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Figure 32: Depression visits by strata in South Carolina for 2012 
 
  
Figure 33: Depression visits by strata in Tennessee for 2012 
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Figure 34: Depression visits by strata in Texas for 2012 
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APPENDIX D. ADDITIONAL INFORMATION FOR CHAPTER 5 
D.1  Unmatched Children with Depression 
There are many children with depression in each state that we are not able to match 
to a similar child that does not have depression.  The number of such children in each state 
with each set of characteristics (for those combinations with at least 11 children) are shown 
in Table 42 below. 
 139 
Table 42: Count of unmatched children with depression by state broken down by stratification 
Age Race Gender Urbanicity AL AR CA FL GA LA MN MS NC NY PA SC TN TX 
15 to 17 White F Urban 816 2049 6438 1116 1954 2188 3229 316 5185 2383 1234 1371 5158 3623 
15 to 17 Other F Urban 45 278 7805 978 352 160 938 61 854 2618 191 203 405 9094 
15 to 17 Black F Urban 742 837 3112 1263 2153 1833 846 307 4065 1274 432 836 1788 2749 
15 to 17 White M Urban 327 814 4146 374 880 652 1972 109 2546 840 523 391 2855 1956 
15 to 17 Other M Urban 38 221 4904 778 392 116 465 65 568 1320 88 146 337 4846 
15 to 17 Black M Urban 357 334 2187 552 1133 800 441 179 2278 505 236 278 1109 1601 
15 to 17 White F Suburban 369 1185 362 108 651 796 692 251 1030 396 525 100 2354 779 
15 to 17 White M Suburban 162 321 214 32 277 155 382 105 548 144 185 11 1064 379 
15 to 17 White F Rural 59 924 62  298 108 317 145 95  161  492 76 
15 to 17 Black F Suburban 122 260 15 42 343 299  435 570   81 187 84 
12 to 14 Black F Urban     20   12 682    526 490 
12 to 14 White F Urban     11   12 809    421 416 
15 to 17 Other F Suburban 22 103 91 56 81 26 109 79 208   21 97 602 
12 to 14 Black M Urban         591    398 418 
15 to 17 Black M Suburban 78 76  23 126 92  224 343   29 140 74 
15 to 17 White M Rural 38 313 44  113 21 128 58 12  63  142 41 
15 to 17 Other M Suburban  84 53 46 105 20 52 70 114   11 100 277 
12 to 14 White M Urban         382    124 407 
12 to 14 Other F Urban         95    83 562 
15 to 17 Black F Rural 67 187   95 70  242 21    27  
15 to 17 Other F Rural  50 24  38  283 49     12 21 
12 to 14 Other M Urban         21    30 407 
15 to 17 Black M Rural 22 74   91 28  100     19  
15 to 17 Other M Rural  75 15  43  92 43     19 14 
15 to 17 White F Unknown 17    17   39  18     
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Age Race Gender Urbanicity AL AR CA FL GA LA MN MS NC NY PA SC TN TX 
12 to 14 White F Suburban             23 29 
15 to 17 White M Unknown 13       20  14     
15 to 17 Black F Unknown 13       22       
15 to 17 Black M Unknown        22       
15 to 17 Other F Unknown        12       
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D.2  Pairs Where One Child Has No Utilization or Expenditures 
Tables 43 through 46 show the number of pairs for each visits type in which one of 
the children has visits and charges and the other does not.  This is important when 
considering the difference in charges especially because we have many children with a 
charge amount of 0 for a particular visit type because they do not have visits of that type, 
not because the charge was 0 for visits that occurred.  The results comparing the median 
charges may be different for a comparison that excludes these zero values and conducts the 
comparison using only the pairs in which both children have non-zero charges.  However, 
removing all of the pairs in which one child has no visits would introduce unnecessary bias 
into the analysis. 
Table 43: Number of pairs of children in which one child has visits or charges in the 
IP table and the other does not have any visits or charges.  The utilization and 
charges for children without visits (or charge amounts) of a particular type are 0s.  
Ex: # Depression 0s is the number of pairs in which the child with depression has no 
utilization or charges but the child without depression does have visits or charges.  
 IP 








# Depression 0s 
# Non- 
Depression 0s 
AL 10863 9044 9832 9044 9832 
AR 14212 12745 13621 12745 13621 
CA 111308 100563 108925 101991 109161 
FL 26389 22607 24748 22607 24748 
GA 20896 18268 19537 18268 19539 
LA 15170 13504 14354 13504 14354 
MN 17411 15965 16923 16719 17141 
MS 8671 7108 7870 7113 7879 
NC 16049 14584 15264 14584 15264 
NY 44020 39085 41792 40157 42135 
PA 11930 11103 11728 11103 11728 
SC 11376 10171 10809 10172 10809 
TN 8940 8183 8590 8234 8621 
TX 42546 37159 39154 37176 39197 
 142 
Table 44: Number of pairs of children in which one child has units or charges in the 
RX table and the other does not have any units or charges.   
 RX 








# Depression 0s 
# Non- 
Depression 0s 
AL 10863 1311 3542 1311 3542 
AR 14212 2151 5031 2151 5031 
CA 111308 30058 81160 30066 81161 
FL 26389 5838 14151 5841 14152 
GA 20896 2946 6524 2946 6525 
LA 15170 2397 6854 2397 6854 
MN 17411 2962 7658 2983 7685 
MS 8671 1001 2903 1002 2903 
NC 16049 2379 4070 2379 4070 
NY 44020 8404 21193 8420 21237 
PA 11930 4399 7820 4399 7820 
SC 11376 3076 5346 3076 5346 
TN 8940 804 1807 804 1807 
TX 42546 5199 10665 5457 11062 
Table 45: Number of pairs of children in which one child has visits or charges in the 
OT table and the other does not have any visits or charges.   
  OT 
   Visits Charges 
State 






# Depression 0s 
# Non- 
Depression 0s 
AL  10863 165 373 428 1356 
AR  14212 237 638 782 1501 
CA  111308 6300 56520 17166 68384 
FL  26389 1277 3436 2818 8687 
GA  20896 139 462 1126 2710 
LA  15170 170 1739 172 1751 
MN  17411 436 1385 441 1404 
MS  8671 466 1209 466 1215 
NC  16049 130 193 130 193 
NY  44020 1360 5450 1384 5613 
PA  11930 153 664 3109 5654 
SC  11376 163 267 163 267 
TN  8940 12 89 359 861 
TX  42546 655 1256 1792 3754 
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Table 46: Number of pairs of children in which one child has charges of any kind 
and the other does not.   
 Total 








AL 10863 374 1282 
AR 14212 695 1402 
CA 111308 13398 66696 
FL 26389 2473 8257 
GA 20896 982 2479 
LA 15170 144 1669 
MN 17411 391 1327 
MS 8671 415 1137 
NC 16049 123 190 
NY 44020 1227 5292 
PA 11930 2926 5233 
SC 11376 150 262 
TN 8940 301 741 
TX 42546 1588 3389 
D.3  Median Utilization and Expenditures 
Tables 47 and 48 show the median utilization and expenditures for IP, OT, and RX claims 







Table 47: Median number of visits (or units for RX) and charge amounts per patient 
















AL 3.3 $220.00 0.012 $0.00 22.7 $39.26 $344.80 
AR 3.9 $252.50 0.008 $0.00 15.9 $25.04 $335.50 
CA 2.8 $59.46 0.008 $0.00 8.3 $3.80 $77.60 
FL 3.2 $211.20 0.000 $0.00 12.1 $14.52 $292.40 
GA 3.8 $165.00 0.011 $0.00 17.7 $18.45 $228.60 
LA 5.6 $483.50 0.015 $0.00 20.9 $44.33 $617.10 
MN 3.0 $134.40 0.006 $0.00 17.8 $6.00 $167.50 
MS 2.5 $338.70 0.013 $0.00 20.0 $32.30 $443.30 
NC 5.4 $349.20 0.007 $0.00 17.2 $32.45 $456.60 
NY 2.6 $194.10 0.015 $0.00 15.5 $22.10 $307.80 
PA 3.0 $103.20 0.005 $0.00 6.8 $12.86 $166.90 
SC 3.0 $259.50 0.008 $0.00 6.7 $9.55 $308.20 
TN 3.5 $133.20 0.007 $0.00 23.3 $39.63 $211.30 
TX 3.6 $255.00 0.011 $0.00 1093.0 $64.90 $498.30 
Table 48: Median number of visits (or units for RX) and charge amounts per patient 


















AL 5.5 $382.30 0.00879 $0.00 6.6 $8.71 $440.70 
AR 7.3 $467.00 0.00358 $0.00 4.0 $4.69 $492.00 
CA 0.0 $0.00 0.00214 $0.00 0.0 $0.00 $0.00 
FL 3.1 $111.40 0.00973 $0.00 0.0 $0.00 $131.90 
GA 6.0 $218.60 0.01327 $0.00 6.4 $4.72 $255.40 
LA 6.4 $404.00 0.01032 $0.00 2.3 $3.39 $454.00 
MN 6.0 $169.10 0.00224 $0.00 1.6 $0.40 $181.20 
MS 4.0 $436.40 0.00871 $0.00 5.8 $7.14 $475.30 
NC 8.0 $420.40 0.00649 $0.00 8.3 $11.25 $472.60 
NY 4.3 $242.30 0.00961 $0.00 0.8 $0.70 $280.10 
PA 3.4 $15.89 0.00206 $0.00 0.0 $0.00 $30.52 
SC 5.3 $392.60 0.00568 $0.00 0.9 $0.85 $415.60 
TN 7.1 $232.60 0.00357 $0.00 9.5 $12.78 $278.70 




D.4  Statistical Test Results 
Table 49 shows the p values for the Wilcoxon tests for IP and RX utilization and charges, 
and Table 50 and Table 51 contain the results for utilization and charges in the four OT 
subsets.  These tests were conducted on the subset of pairs in which at least one child in 
the pair had a claim for the particular type (IP, OT-ED etc). 
Table 49: Number of pairs of children with visits by type, and p-values for the one-
sided Wilcoxon test comparing monthly visits/prescription units and charges per 
person for IP and RX services between the depression population and the non-
depression population. Significant p-values (p<0.0071) are highlighted in green 













AL 2633 1.58E-23 1.42E-31 10245 6.5E-228 9E-181 
AR 1977 2.13E-65 7.24E-61 13113 0 2.5E-260 
CA 12697 0 0 87517 0 0 
FL 5067 7.1E-120 3.7E-99 22655 0 0 
GA 3727 1.12E-48 1.58E-40 19479 4.6E-214 5E-258 
LA 2357 3.6E-37 5.04E-32 13913 0 0 
MN 1868 1.53E-84 3.64E-29 15646 0 0 
MS 2137 8.28E-37 7.98E-46 8165 9.1E-166 2.3E-162 
NC 2142 1.88E-25 1.22E-25 15107 5.6E-142 6.1E-135 
NY 6775 7.9E-128 3.68E-71 38895 0 0 
PA 1004 1.49E-51 2.62E-44 8681 2.4E-232 1.5E-247 
SC 1697 2.76E-33 6.42E-33 9569 1.1E-195 5.3E-142 
TN 1055 4.01E-27 1.48E-26 8631 2.5E-138 4.72E-77 
TX 8171 1.36E-51 3.57E-52 40186 2.5E-134 4.3E-174 
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Table 50: Number of pairs of children with visits by type and p-value for the one-
sided Wilcoxon test comparing monthly visits and charges per person for OT 
hospital and office visits between the depression population and the non-depression 
population. Significant p-values (p<0.0071) are highlighted in green 











AL 9842 6.06E-45 1.04E-09 10692 1.24E-05 0.019367 
AR 13352 1.38E-58 8.7E-65 13938 0.953808 0.018498 
CA 77604 0 0 97801 0 0 
FL 22024 0 0 24267 1.8E-110 1.9E-190 
GA 17367 1.7E-120 1.4E-99 20251 0.002799 1.4E-55 
LA 13881 2.8E-262 1.2E-289 14967 2.2E-170 1.4E-182 
MN 15529 1.9E-165 1.3E-127 17066 0.999995 0.48697 
MS 6492 7.23E-48 2.27E-34 8450 0.117307 2.82E-05 
NC 10816 1.7E-13 1.12E-09 15672 6.88E-25 1.56E-56 
NY 40906 0 0 41748 0.999996 1.92E-35 
PA 8947 3.2E-293 0 10423 0.000373 1.9E-31 
SC 9123 1.06E-43 1.21E-52 10800 1 1 
TN 8273 2.32E-21 3.5E-171 8819 1 0.000333 
TX 37986 1.5E-87 6E-151 41976 1 1 
Table 51: Number of pairs of children with visits by type and p-value for the one-
sided Wilcoxon test comparing monthly visits and charges per person for OT ED 
and Other visits between the depression population and the non-depression 
population. Significant p-values (p<0.0071) are highlighted in green 











AL 10758 1 1 10854 1 1 
AR 14042 1 1 14198 1 1 
CA 102737 1 1 108063 1.79E-77 2.2E-128 
FL 25368 1 1 26190 1 1 
GA 20570 1 1 20889 1 1 
LA 15063 1 1 15158 1 1 
MN 17196 1 1 17352 1 1 
MS 8550 1 1 8587 1 1 
NC 15850 1 1 16035 1 1 
NY 43399 1 1 43844 1 1 
PA 10990 1 1 11924 1 1 
SC 11002 1 1 11366 1 1 
TN 8862 1 1 8938 1 1 
TX 42226 1 1 42503 1 1 
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AR-AL 0.9643 0.9999 1.0000 1.0000 0.0000 0.9630 0.9980 
CA-AL 0.0018 0.9600 1.0000 1.0000 0.0000 0.0000 0.0017 
FL-AL 0.9787 0.0968 1.0000 1.0000 1.0000 1.0000 0.9863 
GA-AL 0.0000 0.7418 1.0000 1.0000 0.9205 0.9950 1.0000 
LA-AL 0.9857 0.9981 1.0000 1.0000 0.0000 0.5789 0.9083 
MN-AL 0.9997 0.9996 1.0000 1.0000 0.0000 0.0980 0.9897 
MS-AL 0.9234 1.0000 1.0000 1.0000 0.9793 0.8915 0.9953 
NC-AL 0.2355 0.9999 1.0000 1.0000 0.1214 0.3528 0.9839 
NY-AL 0.2643 0.9827 0.0000 0.0000 0.4665 0.1314 0.0000 
PA-AL 1.0000 1.0000 1.0000 1.0000 0.3641 0.3110 0.9378 
SC-AL 1.0000 1.0000 1.0000 1.0000 0.9984 0.9897 1.0000 
TN-AL 1.0000 0.9999 1.0000 1.0000 0.0023 0.0143 0.7030 
TX-AL 0.0000 0.4123 1.0000 0.9995 0.0000 0.0032 0.1628 
CA-AR 0.3333 0.1870 1.0000 1.0000 0.0000 0.0000 0.0000 
FL-AR 1.0000 0.4388 1.0000 1.0000 0.0000 0.9772 1.0000 
GA-AR 0.0000 0.9916 1.0000 1.0000 0.0000 0.1006 0.9937 
LA-AR 1.0000 1.0000 1.0000 1.0000 0.0022 1.0000 1.0000 
MN-AR 1.0000 1.0000 1.0000 0.9996 0.0059 0.0000 0.2934 
MS-AR 1.0000 0.9971 0.9982 1.0000 0.0000 0.0601 0.5410 
NC-AR 0.0002 1.0000 1.0000 1.0000 0.0000 0.0007 0.2676 
NY-AR 0.9992 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
PA-AR 0.6709 1.0000 1.0000 1.0000 0.0000 0.0009 0.1852 
SC-AR 0.6430 1.0000 1.0000 1.0000 0.0000 0.1563 0.8859 
TN-AR 0.9999 1.0000 1.0000 1.0000 0.0000 0.0000 0.0654 
TX-AR 0.0000 0.9091 1.0000 1.0000 0.0000 0.3774 0.8779 
FL-CA 0.0090 0.0000 1.0000 1.0000 0.0000 0.0000 0.0000 
GA-CA 0.0000 0.0000 1.0000 1.0000 0.0000 0.0000 0.0000 
LA-CA 0.1594 0.0431 1.0000 1.0000 0.0000 0.0000 0.0000 
MN-CA 0.0099 0.0507 1.0000 1.0000 0.0000 0.2998 0.0638 
MS-CA 0.9316 0.9998 0.9999 1.0000 0.0000 0.1068 0.5758 
NC-CA 0.0000 0.1157 1.0000 1.0000 0.0000 0.0586 0.1267 
NY-CA 0.4903 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 
PA-CA 0.0000 0.7236 1.0000 1.0000 0.0000 0.3531 0.6338 
SC-CA 0.0000 0.5059 1.0000 1.0000 0.0000 0.0014 0.0301 
TN-CA 0.0952 0.4407 1.0000 1.0000 0.0000 1.0000 0.9967 
TX-CA 0.0000 0.0000 1.0000 0.6084 0.0000 0.0000 0.0000 
GA-FL 0.0000 0.9938 1.0000 1.0000 0.8025 0.7409 0.9434 
















MN-FL 1.0000 0.4449 1.0000 1.0000 0.0000 0.0010 0.0716 
MS-FL 1.0000 0.0531 0.9993 1.0000 0.8691 0.4685 0.3013 
NC-FL 0.0000 0.3884 1.0000 1.0000 0.0231 0.0185 0.0658 
NY-FL 0.9306 0.2989 0.0000 0.0000 0.1133 0.0002 0.0000 
PA-FL 0.6784 0.2071 1.0000 1.0000 0.1762 0.0232 0.0480 
SC-FL 0.6500 0.4157 1.0000 1.0000 0.9712 0.7842 0.6902 
TN-FL 1.0000 0.7810 1.0000 1.0000 0.0002 0.0002 0.0147 
TX-FL 0.0000 0.9975 1.0000 0.9857 0.0000 0.0000 0.7361 
LA-GA 0.0000 0.9996 1.0000 1.0000 0.0000 0.0044 0.7819 
MN-GA 0.0000 0.9956 1.0000 1.0000 0.0000 0.5406 0.9403 
MS-GA 0.0000 0.5350 1.0000 1.0000 0.0870 0.9999 0.9810 
NC-GA 0.0376 0.9902 1.0000 1.0000 0.9144 0.9235 0.9197 
NY-GA 0.0000 0.9983 0.0000 0.0000 1.0000 0.6798 0.0000 
PA-GA 0.0000 0.9099 1.0000 1.0000 0.9949 0.8768 0.8071 
SC-GA 0.0000 0.9817 1.0000 1.0000 0.1491 1.0000 1.0000 
TN-GA 0.0000 0.9993 1.0000 1.0000 0.0912 0.1164 0.4692 
TX-GA 0.7736 1.0000 1.0000 0.9635 0.0000 0.0000 0.0173 
MN-LA 1.0000 1.0000 1.0000 0.9997 1.0000 0.0000 0.0432 
MS-LA 1.0000 0.9760 0.9990 1.0000 0.0000 0.0048 0.1751 
NC-LA 0.0004 1.0000 1.0000 1.0000 0.0000 0.0000 0.0392 
NY-LA 0.9921 1.0000 0.0000 0.0000 0.0000 0.0000 0.0000 
PA-LA 0.7722 1.0000 1.0000 1.0000 0.0000 0.0000 0.0273 
SC-LA 0.7463 1.0000 1.0000 1.0000 0.0000 0.0143 0.4720 
TN-LA 1.0000 1.0000 1.0000 1.0000 0.0234 0.0000 0.0082 
TX-LA 0.0000 0.9861 1.0000 0.9999 0.0000 0.9328 0.9989 
MS-MN 0.9995 0.9893 0.9983 1.0000 0.0000 0.9995 1.0000 
NC-MN 0.0021 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 
NY-MN 0.7818 1.0000 0.0000 0.0000 0.0000 1.0000 0.0000 
PA-MN 0.9526 1.0000 1.0000 1.0000 0.0000 1.0000 1.0000 
SC-MN 0.9407 1.0000 1.0000 1.0000 0.0000 0.9145 1.0000 
TN-MN 1.0000 1.0000 1.0000 1.0000 0.0049 0.9972 0.9987 
TX-MN 0.0000 0.9270 1.0000 0.7769 0.0000 0.0000 0.0000 
NC-MS 0.0009 0.9958 1.0000 1.0000 0.0010 1.0000 1.0000 
NY-MS 1.0000 0.8992 0.0000 0.0000 0.0060 1.0000 0.0000 
PA-MS 0.6095 1.0000 0.9999 1.0000 0.0084 1.0000 1.0000 
SC-MS 0.5827 0.9997 0.9999 1.0000 1.0000 1.0000 1.0000 
TN-MS 0.9987 0.9976 1.0000 1.0000 0.0000 0.8579 0.9999 
TX-MS 0.0000 0.2513 0.9996 0.9992 0.0000 0.0000 0.0026 
















PA-NC 0.5877 1.0000 1.0000 1.0000 1.0000 1.0000 1.0000 
SC-NC 0.6607 1.0000 1.0000 1.0000 0.0015 0.9965 1.0000 
TN-NC 0.0724 1.0000 1.0000 1.0000 0.9291 0.9469 0.9995 
TX-NC 0.7124 0.8889 1.0000 0.9980 0.0000 0.0000 0.0000 
PA-NY 0.0281 0.9992 0.0000 0.0000 1.0000 1.0000 0.0000 
SC-NY 0.0269 1.0000 0.0000 0.0000 0.0087 0.9827 0.0000 
TN-NY 0.8700 1.0000 0.0000 0.0000 0.1679 0.8789 0.0000 
TX-NY 0.0000 0.8998 0.0000 0.0000 0.0000 0.0000 0.0000 
SC-PA 1.0000 1.0000 1.0000 1.0000 0.0149 0.9887 0.9992 
TN-PA 0.9982 1.0000 1.0000 1.0000 0.8554 0.9913 1.0000 
TX-PA 0.0006 0.6584 1.0000 0.9997 0.0000 0.0000 0.0000 
TN-SC 0.9973 1.0000 1.0000 1.0000 0.0000 0.3998 0.9612 
TX-SC 0.0012 0.8756 1.0000 0.9988 0.0000 0.0000 0.0120 
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